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Abstract 
Podophyllotoxins, and their derivatives, have shown significant anti-proliferative properties. Etoposide 
and other semi-synthetic analogues, such as teniposide, have been successfully employed as clinical anti-cancer 
agents. 4-Aza-podophyllotoxins, which are structurally simplified synthetic analogues of podophyllotoxin, have 
been successfully synthesised and have shown comparable biological activity to the naturally occurring (-) 
podophyllotoxin. To further investigate the method of inhibition of this class of compounds, which have been 
reported to act as either tubulin inhibitors or topoisomerase II poisons, two libraries of 4-aza-podophyllotoxin 
analogues were synthesised. The biological test results from the first library of analogues was used to inform the 
synthesis of a second library of compounds. The first library contains a diverse group of twelve 4-aza-
podophylltoxin analogues, six with differences in the 4N- position. Half of these compounds were modelled after 
etoposide, and half modelled after the naturally-occurring (-)-podophyllotoxin. This was achieved through N-
functionalization of the starting material, an aniline, prior to its use in a multicomponent reaction with tetronic 
acid and a functionalized benzaldehyde. The second library of four compounds was generated using an azide 
alkyne cycloaddition to modify two alkyne-containing compounds from the first library. The first library has 
shown IC50 values of nano-molar concentrations (125-250 nM) against a WHCO1 oesophageal cell line assay. A 
small structure activity relationship from these biological results was obtained. 
Keywords: Podophyllotoxin, synthesis, anti-cancer, 4-aza-podophyllotoxin, multicomponent reaction. 
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Opsomming 
Podofilotoksien, en hul afgeleides, het beduidende anti-proliferatiewe eienskappe. Etoposiede en ander 
semi-sintetiese analoë, soos teniposiede, is suksesvol as kliniese teenkankermiddels gebruik. 4-Aza- 
podofilotoksien, wat struktureel vereenvoudigde sintetiese analoë van podofilotoksien is, is suksesvol gesintetiseer 
en het vergelykbare biologiese aktiwiteit getoon met (-) podophyllotoxin wat natuurlik voorkom in plante. Twee 
groepe van 4-aza-podofilotoksien analoë is gesintetiseer sodat die metode van inhibering van hierdie klas 
verbindings verder ondersoek kan word. Die inligting van die biologiese toetsresultate uit die eerste groep met 
analoë, is gebruik in die sintese van 'n tweede groep van verbindings. Die eerste groep bevat 'n uiteenlopende 
groep van twaalf 4-aza-podofilotoksien-analoë waarvan ses verskille toon in die 4N-posisie. Die helfte van hierdie 
verbindings gemodelleer na etoposied en die ander is helfte gemodelleer na (-) podofilotoksien vat in natuur 
voorkom. Dit is bereik deur N-funksionalisering van die uitgangsmateriaal, 'n anilien, voordat dit in 'n 
multikomponentreaksie met tetronsuur en 'n gefunksionaliseerde bensaldehied gebruik is. Die tweede groep van 
vyf verbindings is gegenereer met behulp van 'n aziedalkyne-cycloaddition om twee alkienbevattende verbindings 
uit die eerste groep te verander. Die eerste biblioteek het IC50-waardes van nano-molêre konsentrasies (125-250 
nM) teen 'n WHCO1-slukderm-sellyn-toets getoon. Ons het daarin geslaag om 'n klein 
struktuuraktiwiteitsverhouding te genereer uit hierdie biologiese resultate. 
 
Sletulwoorde: Podofilotoksien, sintese, anti-kanker, 4-aza-podofilotoksien, multikomponentreaksie. 
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Introduction 
Podophyllotoxins and their derivatives (compound 1, see Figure 1), are known to have inhibitory 
activity against various cancer cell lines. Therefore, they have been well researched and form a key part of 
the field of medicinal chemistry.1 Previously, podophyllotoxins have been extracted from natural materials, 
particularly plants from the genus podophyllum.2 The yields for these naturally extracted cyclolignans have 
been very low, 0.4 – 2.5% mass per mass,3 which creates the need for fully synthetic analogues. The 
promising bioactivity exhibited by these compounds resulted in the development of new synthetic strategies 
to produce the compounds in acceptable yields. Seven podophyllotoxin derivatives have been developed as 
anti-cancer agents since the structure of naturally occurring (-)-podophyllotoxin was confirmed 1951,3 and 
have undergone clinical trials as potential novel clinical treatments. These compounds are: etoposide (2*1), 
teniposide, etopophos (currently in use1), NK-611, GL331, NPF, and TOP53 (see later in Figure 5).1 There 
are, however, numerous compounds within this group that remain unstudied, or have shown serious side 
effects such as severe gastrointestinal symptoms, which made them unsuitable as anti-cancer agents.*2  
The structure-activity relationship studies of these compounds have shown that they can be heavily 











Figure 1: Structure of (-)-podophyllotoxin, a member of the podophyllotoxin class of compounds 
(1), and etoposide (2).2,3 
 
 
*1 Throughout this text numbers in bold are those that have been assigned to compounds that form part of this research. 
*2 The introduction and the description of the general instruments and solvents used (in Chapter 3), have been adapted from: Gould, K.T. and van Otterlo, 
W.A.L Novel synthesis of 4-aza-podophyllotoxin analogues and their potential as anti-cancer agents. Stellenbosch University Honours paper (Unpublished). 2017 
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(-)-Podophyllotoxin, the naturally extracted cyclolignan, has demonstrated tubulin polymerisation 
inhibition, while Etoposide (2) and most 4-N functionalised 4-aza-podophyllotoxin synthetic derivatives 
(Figure 2) have been shown to be both tubulin inhibitors and/or topoisomerase II poisons. Tubulin, an α-β 
heterodimer forms the core of microtubules that are vital for mitosis (-)-Podophyllotoxin (1) inhibits tubulin 
polymerisation, which affects the cells ability to divide, and thus inducing apoptosis. 4 Etoposide (2) and 
its analogues, unlike (-)-Podophyllotoxin, have displayed biological activity by acting as a topoisomerase 
II poison.5 Topoisomerase II is understood to interact with the supercoiled DNA double helix.6 By 
disrupting the action of topoisomerase II, etoposide (2) prevents the DNA double helix from re-ligating 
after uncoiling during the mitotic stage and during protein synthesis. Unable to re-form the double helix, 
cell death is initiated. Unfortunately (-)-podophyllotoxin (1) and etoposide (2) induce death in both cancer 
and healthy human cells. This leads to inefficient treatment of the cancer due to the simultaneous death of 
normal and cancerous cells.5 
Synthesis of synthetic derivatives of (-)-podophyllotoxin, has been a stumbling block for many 
years. This is due to the complex stereochemical elements displayed by the compound. Several synthetic 
strategies were discussed in a review by Botes et al.7 and Yu, et al.,1 including also the development of one-
pot multicomponent reactions (MCRs) used for the synthesis of 4-aza-podophyllotoxins (Figure 2).  
 
Figure 2: Generalized structure of the 4-aza-podophyllotoxin analogues synthesized in this project, 
where R1 is a series of alkyl groups and R2 consists of either a phenolic or methoxy moiety 
The research undertaken and described in this thesis was performed with the aim of synthesizing a 
series of diverse 4N-functionalized 4-aza-poodphylltoxin analogues that could act as anti-cancer agents. 
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These compounds were tested against several cancer cell lines, most significantly an esophageal cancer cell 
line (WHCO1). The results were used to synthesize a second diverse library. It was hoped that these 
compounds would yield a new group of potential anti-cancer agents. 
This, manuscript consists of five chapters. Chapter 1 provides background information on research 
into 4-aza-podophyllotoxin analogues. The second chapter presents the results of the syntheses performed 
for this project. Chapter 3 describes the reactions performed during experimentation. Chapter 4 presents the 
biological test results obtained for the synthesized libraries. The thesis concludes with a summary of the 
research and discusses the future lines of inquiry. 
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 Chapter 1 
What follows is a discussion on the traits of cancer and current treatment options. At present 60% 
of all known anti-cancer drugs are derived from natural products.8 The second section of this chapter  briefly 
discusses the history of natural products, their link to anti-cancer agents and the role natural products play 
in modern drug discovery. Finally, this chapter discusses podophyllotoxin and the synthesis of 4-aza-
podophylltoxin analogues that were the fulcrum of this research.  
1.1 Cancer 
Cancer is one of the most prevalent killers in the modern world. It is ranked as the 2rd largest cause 
of death in the human population by the WHO.9 Almost all of us have had some experience with cancer, 
either through exposure to a sick loved-one, or ourselves. Approximately 30 years ago the life expectancy 
of cancer patients after diagnosis was five years. Now the life expectancy of a cancer patient has risen to a 
65% chance of survival after five years. Part of the reason for the improved therapeutic outcome is that 47 
new and more efficacious anti-cancer drugs were put into production between 2000 and 2010, and 27 
between 1990 and 2000.10  
  The hallmarks of malignant cancer 
The classic indicators of malignant cancer can be attributed to morphological, molecular and 
cellular factors, commonly known as the “hallmarks” of cancer.10 These traits have been extensively 
reviewed by Hanahan & Weinberg who coined the term in 2000 and reviewed them again in 2017. This 
section will focus on six characteristics of cancer cells. 
i. Self-sufficient growth signaling 
Typically, cell growth is carefully controlled, with the number of cells at rest, or in replicative and 
apoptotic stages remaining in balance. Tumor, or neoplasm formation requires more cells to be in the 
rest and replicative cell stages than those in the apoptotic stage. This is achieved by self-production of 
the hormones responsible for cell growth signaling and/or errors in the growth promotion receptors. If 
either of these occur, a positive feedback loop is created, known as autocrine stimulation. This leads to 
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continuous growth of cancer cells. One such example is in the SOS-Ras-Raf-MAPK signal transduction 
pathway.11,12 
ii. Insensitivity to antigrowth signaling 
If the cancer cell shows mutations in the antigrowth hormone receptors it can bypass the checkpoints 
during the cell cycle that prevent faulty cells from replicating. These checkpoints occur between the 
G1 and S, S and G2 and G2 and M phases of the cell cycle. Typically, a healthy cell will assess whether 
to continue towards mitosis at these checkpoints. In cancer this does not occur, and mitosis is almost 
always instigated as a result of bypassing these checkpoints.10 
iii. Apoptosis evasion 
During normal cell growth, if a cell does not receive pro-survival signals from the extracellular matrix 
or incurs damage to its DNA, apoptosis will be triggered. The cell will then begin to die, beginning 
with the disruption of the cellular membranes and ending with the cell being engulfed by the 
phagosomes, tissues and cells around it. This process will usually be completed within 24 hours in 
normal human cells. Cancer cells can evade this through various mutations of either the proapoptotic 
(Bc1-2 family), anti-apoptotic receptor proteins, or by inactivation/deletion of the p53 tumor suppressor 
genes.10  
iv. Unlimited replicative potential 
Healthy human cells, unlike cancer cells, have limited proliferative potential due to the shortening of 
the telomeres on chromosomes. Once a healthy cell achieves this limit of approximately 60-70 divisions 
it will undergo senescence due to the inability to completely replicate the 3’ end of the DNA strand 
during the S phase of the cell cycle. Cancer cells can evade this through expression of hTERT, a 
telomerase catalytic subunit, avoiding the shortening of the telomeres.11 
v. Sustained angiogenesis 
Tumors, like normal tissues require the flow of nutrients, and this is facilitated through blood vessels. 
Human tissues typically only induce the growth of blood vessels during wound healing and commonly 
only through endothelial tissues. To facilitate blood vessel growth, tumors secrete growth factors 
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inducing healthy endothelial, and other related tissues, to facilitate angiogenesis. The healthy cells will 
therefore produce blood vessels that will feed the tumor.13 
vi. Tissue invasion and metastasis  
This is the most dangerous part of cancer, causing 90% of deaths due to cancer. Cancer cells can spread 
to unrelated and surrounding tissues by moving through the extracellular matrix or blood vessels. These 
pioneer cells can then establish secondary tumors in other parts of the body or tissues surrounding the 
original tumor.11 
 Chemotherapy 
There are typically three methods of treatment for cancer, namely: radiation therapy, chemotherapy 
and surgery. While surgery and radiation therapy are crucial methods, the most important is chemotherapy. 
Tumors can be removed with surgery, however, frequently reduction of the size of the neoplasm is required 
before surgery, which is achieved through either radiation therapy or chemotherapy.14 
Surgery cannot treat all cancers, for example leukemia, and can be risky to the patient depending 
on the location of the tumor.15 Surgery can also not treat the dispersion of small cancer cells caused by 
metastasis, thus requiring it to be used with radiation and/or chemotherapy. Like surgery, radiation, and 
ionizing radiation, has met with success in the treatment of localized cancers. Though radiation can be 
accurate, it will almost always damage the healthy cells around the tumor.15 Radiation treatment, however 
accurate, has similar if not worse side effects, such as sterility, nausea, hair loss, and diarrhea, when 
compared to chemotherapy. Because of these effects, chemotherapy is often the preferred method of 
treatment. It not only helps to manage malignant tumors, but can also target cancer cells throughout the 
body and can be adjusted based on the type of cancer, as well as its susceptibility to different 
chemotherapeutic agents.14 While the other methods are still in use and are viable treatments, this section 
will focus on chemotherapy for the treatments of cancer cells.  
Ideally chemotherapeutics should be selective for cancer cells and leave the host undamaged, 
however, due to the currently insufficient understanding of the chemistry and biology of the human body 
this is almost impossible. In 2018, the Nobel prize for chemistry was awarded for antibody targeting for 
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autoimmune diseases.16 It is hoped that the methods described by Frances Arnold, George Smith and 
Gregory Winter will open a new future for anti-cancer research. However, until this can be achieved on 
large-scale and human genome sequencing costs decrease, the need for conventional small molecule anti-
cancer agents will remain.  
There are typically two main small molecule chemotherapeutic drug development tactics, the first 
being cytotoxins, the second targeted therapeutics. Cytotoxins often lead to broad cell death, and frequently 
target multiple sites. For the most part these drugs have been developed and put into practice without their 
mechanisms of action being thoroughly understood. Targeted therapeutics instead aim to only impact one 
specific intracellular target site, such as tyrosine kinase inhibitors. They have been developed using 
molecular in silico screening, high-throughput screening or protein-based approaches.10 The cytotoxic 
drugs currently in use are often discovered from natural products using the P338 mouse model in vivo, or 
cellular screening methods. Cytotoxins have been found to mostly target microtubules, damage DNA or 
inhibit DNA synthesis.10  
Some cytotoxins which exhibit mechanisms that are not thoroughly understood, and exhibit serious 
side effects like hair loss or gastrointestinal toxicity, are still used to treat cancer as they are effective.14 
Targeted therapies are also effective; however, drug resistance is often acquired, and mutated cancer cells 
within a tumor that are not sensitive to the desired target site will continue to proliferate. Due to these 
conflicting benefits and drawbacks, drugs from both cases are often employed together. Treating cancer in 
a patient can often involve the simultaneous use of five to six different chemotherapeutics to treat one 
patient.10 Due to the diversity of the human genome and their respective cancers, until our technological, 
chemical and biological understanding improves, we will require a diversity of anti-cancer agents. 
Podophyllotoxin and its analogues are an example of a cytotoxin; however, as research into the 
field of podophyllotoxins has improved, their mechanism of action has been uncovered, and we can begin 
to blend targeted therapeutics with conventional cytotoxins as a way forward. Since more than 60% of 
currently discovered anti-cancer agents are inspired by natural products, like podophyllotoxin,17 it is 
imperative that we continue to explore this resource for more potential anti-cancer agents. 
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1.2  Natural products  
Humans have a long history of using natural products in medicines. Some suggest the use of natural 
products as medicine extends beyond our recorded human history, going back almost 60 000 years. In 1975 
a paper published by Solecki suggested that pollen deposits at a Neanderthal grave site indicated their early 
understanding of the medicinal properties of plant materials.18 This section discusses compounds that can 
be included under the natural products banner; the history of natural products in medicines; and their 
importance to modern medicine. It concludes by discussing podophyllotoxin, the inspiration for this thesis, 
and how podophyllotoxin came to be a prevalent part of modern anti-cancer technology.  
 History of natural products 
Natural products can be broadly described as components of living organic matter that humans can 
use. This encompasses everything from paper and cotton, to penicillin. This chapter will exclusively focus 
on those natural products that have medicinal value. It has been theorized that many natural products that 
are used in medicine stem from secondary metabolites. This mainly includes compounds that are not 
necessary for the primary growth and development of the organism,12 but rather compounds that either 
allow an organism to thrive, outcompete other species, or make use of excess nutrients.19 Despite this 
understanding, the role of secondary metabolites is not clear in many organisms, unlike microbial 
production of anti-biotics. There is still much debate as to why organisms would develop these components, 
and why so many of them are medicinally useful. The most popular theories center around co-evolution, 
recently the theory of xenohormesis.19  
In 1975, scientist Ralph S. Solecki discovered pollen deposits at a Neanderthal burial site located 
in Northern Iraq. The bodies recovered at the site showed the presence of at least seven species of plant, 
including plants of the genus Achillea (Yarrow), which is known for its medicinal properties. Solecki 
suggests that presence of these plants, and others with medicinal properties, could point towards early 
medicine. While it is uncertain that this was the intention of early humanity, there is no doubt that humans 
have a long history of using natural products in medicine.18  
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For many years the biology of disease was not well understood, even now our understanding has 
many gaps. Initially our understanding was patchy and rudimentary at best. Many early drugs such as opium, 
alcohol, salicylic acid (5) and quinine (4) predate modern medicine (see Figure 3).20 One of the oldest 
records of human history dates to ancient Mesopotamia (2600 BC). It depicts in cuneiform, on clay tablets, 
the use of natural products to cure a variety of ailments and diseases. Other historical records, such as The 
Chinese Materia Medica from 1100 BC, and Erbers Papyrus from Egypt 1500 BC, further depict humanities’ 
use of natural products. These records refer to thousands of plants and their potential medicinal uses. Other 
such records come from ancient India (Ayurvedic hymns, 1000 BC), ancient Greece (De Materia Medica, 
100 AD) and other parts of the world.21,19 Many encyclopedias and books have since been written, such as 
the works by the Persian philosopher Avicenna, the Cannon Medicinae, summarizing Greek and Roman 
medicine of the time. The Pen-ts’ as kang mu in (1596 AD) by Li Shih-Chen records 1898 herbal drugs 
and 8160 prescriptions from China.21 
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Figure 3: The structure of quinine (4) and salicylic acid (5). 
In the 16th century German medical doctor and natural scientist, Paracelsus, otherwise known 
Phillip van Hohenheim, formulated the “Doctrine of Signatures” in which he suggested that the physical 
appearance of drugs can be used to identify drugs, and states that each disease has a corresponding cure to 
be found in nature. Though these ideas are no longer considered valid, they are the beginnings of rational 
drug discovery.20  
In the early 1800s American colonists’ lack of easily accessible medicinal knowledge sparked the 
era of household medicine. Various almanacs and publications such as Samuel Thompson’s Thompson’s 
New Guide to Health were made available to the general public and gained popularity.21 Humans have used 
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these products as either wraps for wounds or as chewed herbs, consumed products or even in smoked form. 
It has only been in the last century that we have made use of synthetics in commercial medicines, starting 
with the use of morphine (6, see Figure 4), derived from opium in 1805 and made commercially available 
in 1826 by Merck.22 The first semisynthetic to be marketed was aspirin (7) produced by Bayer in 1899.21 
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Figure 4: The structures of morphine (6), aspirin (7) and colchicine (8). 
Natural products currently play a significant role in medicines, specifically in chemistry and the 
-omics fields. Structure elucidation has played a very large role in this transition, specifically allowing 
chemists to synthesize compounds based on natural products. This transition to synthetic medicines brought 
with it a decrease in the cost of medicine, thus inspiring the use of synthetic compounds in medicine, e.g. 
the discovery of colchicine (8).4  
The first step away from fully natural medicines was characterized by the complete isolation of 
compounds, e.g. quinine (4). Quinine was originally sold and prescribed in its impure form, as bark form 
Cinchona trees and shrubs. In the 1800’s Pelletier and others purified and isolated quinine allowing for its 
use as a medicine in the treatment of malaria. Quinine is still in use as an anti-malarial medicine, and malaria 
has shown surprisingly little development of resistance to the drug.12  
Natural products and anti-cancer chemistry became coupled in the 1950’s when, under Dr Jonathan 
Hartwell, the US National Cancer Institute (NCI) recognized their potential. Many compounds have since 
been discovered and utilized with NCI funding and support.23 
Modern medicine, specifically in drug discovery, still derives many ideas from natural sources, but 
our direct use of natural products has decreased greatly, the largest influencing factor being obtainable 
yields of pure compounds from their natural sources. The use of modern technologies such as combinational 
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chemistry and biosynthetic pathway manipulation, have also lead to a decrease in the prevalence of the use 
of natural products both as extracts and semi-synthetic products.23 
Semi-synthesis involves the modification of compounds starting with the natural product to 
increase its medicinal efficacy. Typically this involves compounds obtained from microbial sources as they 
often produce large amounts of starting material.12 The key drawbacks of semi-synthetics are the necessity 
for the natural product starting material; the need for chemical selectivity during synthesis; and, finally the 
purification of the product, resulting in low yields.12 Etoposide is a good example of successful semi-
synthesis.24 
As time progressed, there was a move away from direct extraction to fully synthetic alternatives. 
This was observable across multiple fields, including the perfumery industry. It was not until the 
popularized use of Chanel No. 5 in 1921, that synthetic compounds became widespread in industry. Natural 
products still do provide of a large portion of potential drug leads.25 
  Natural products as medicines in modern drug discovery 
It is assumed that at least 60% of current medicines are derived from natural products,26 and we 
have only explored less than 10% of our total biodiversity for biologically active compounds useful to 
modern medicine, suggesting a massive untapped resource.22 The same can be said of anti-cancer agents, 
with more than 60% of current anti-cancer agents having been inspired by natural products.27 
Just over 100 years ago due to the ideas of Fischer, and the work of Langly & Ehrlich, work towards 
rational drug design was further improved through the suggestion of the “lock and key” principle. This 
suggested the idea that certain cells have specific receptors that can act as hosts for drugs, and that one need 
only modify the drug until it suits the target receptor This limited the creativity of drug design, as emphasis 
was placed on designing drugs for a particular receptor. Since then this has been further elaborated and 
adjusted with increased knowledge of protein and enzyme structure and their behaviors in space, as well as 
how they fold to accommodate ligands.20  
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 25 
Omics technologies are currently favored for target site discovery and the synthesis of more 
targeted drugs. These include genomics, proteomics, shell interfering RNAs and mouse gene knockout 
models.28 
Currently target discovery methods can be summarized as either ‘molecular’ or ‘systems’. While 
the molecular methods encompass in vitro studies and observations of the mechanics within the cell, or the 
disease, molecular methods focus on identifying very specific intracellular targets and are used extensively 
in oncology. Systems methods are focused on the disease, within the entire host organism, and include in 
vivo studies. They are widely used in epidemiology and pathology.20  
Despite these methods of drug target identification, the need for drug diversity is still high and this 
is where natural products shine. Though most natural products discovered today will not go on to be used 
immediately to generate a lead compound, they do offer a starting point, which, using structure activity 
relationships we can tweak to suit our needs. SAR and Qualitative SAR (QSAR) are the medicinal chemists’ 
best tools for finding new potential drug leads. When harnessing these tools several things need to be kept 
in mind specifically ADME-Tox, bioisoterism, stereochemistry and the Lipinski rule of five. These aspects 
are further outlined by Krogsgaard-Larsen et al.20 
  Current themes in Natural Products Chemistry 
The invention and application of HPLC-MS, GC-MS, two-dimensional chromatography, and other 
modern chromatographic separation techniques has made the discovery of natural product-based drug leads 
significantly easier. This coupled with crystallography, used for protein identification, and NMR 
spectroscopy can make targeted drug discovery even easier as the database begins to grow. Each further 
step towards the improvement of separation and identification techniques makes the discovery of new drugs 
faster and more efficient and when coupled with high throughput-screening makes drug discovery even 
more achievable.28,29,30 
We are, however, still dependent on biological assays, as only 2% of the overall bacteria in the 
world can be cultured in a laboratory, even with modern screening techniques. This creates a gap in the 
potential for discovering new drug leads to combat harmful microbes.32 This said, microbes are also gaining 
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popularity as a source of potential drug leads and are even currently in use in biosynthesis.1 Understanding 
the human microbiome has also shown potential for practical use in treating cancer. A review by Whisner 
& Athena Aktipis discusses research aimed at determining the link between cancer cells and the human 
microbiome. Their research states that microbes and cancer cells can co-evolve within the body and may 
even share nutrients with each other.33 
Alternatively, molecular modeling can be used to predict potential drug leads. Once the target site 
has been identified the tools discussed can be used to narrow down potential modifications of the molecule. 
This method is also currently in use alongside genomics and proteomics to make new potential 
individualized drugs.34 
Natural product chemistry still offers the potential for undiscovered cures or treatments. However, 
as we slowly improve our understanding of the chemistry behind disease we can begin to use modeling to 
predict how to cure disease, without the need for broad spectrum screening, and move towards targeted 
synthesis, and the use of various -omics techniques.35  
1.3 Podophyllotoxin and its analogues as anti-cancer agents 
Podophyllotoxin and its analogues have been extensively researched and reviewed over the last 
century, particularly since the identification of its structure in 1951 by Hartwell and Schrecker.3 Research 
into podophyllotoxin and its analogues have been extensively reviewed by Yu et al. between 2003-2007, 
2008-2010, and most recently in 2017.1 There have also been extensive reviews into 4-aza-podophyllotoxin 
analogues, their uses and total synthesis one such review was done by Botes et al. in 2014 on the synthesis 
of 4-aza-podophyllotoxin analogues by MCR.7 This section gives a brief overview of the research 
performed since podophyllotoxins’ isolation from Podophyllin and focusses on the work towards the fully 
synthetic derivatives, with a targeted focus on 4-aza-podophyllotoxins.  
It has been reported that plants containing podophyllotoxin, specifically those from the 
Podophyllum, Juniperis and Diphylleia genus were used as medicines by the indigenous populations of 
North America and the Himalayas in the form of an aqueous extract.1,3 The first written reports of these 
plants being used as medicines as dates as far back as 1731.3 Podophyllin, in the alcoholic extract from 
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rhizome of Podophyllum was first reported in the United States Pharmacopeia in 1820, and it was then 
referenced again in the English Pharmacopeia in 1864.3,36 The extract, podophyllin, became commercially 
available in the 1850s as a medicine, with it being prescribed, among other things, as a purgative, cathartic 
and anthelminthic. There are also reports of it being used as a rudimentary anti-cancer agent in India in the 
1700s.3  
Between 1942-1946 naturally-occurring (-)-podophyllotoxins’ mode of action became more 
thoroughly understood, and it was removed from the United States Pharmacopeia due to its toxicity.36 It 
was not until its structure was identified chemically in 1951, and proved by a total synthesis, done by 
Gensler et al.,37 that it began to be researched as a potential drug lead. This has since lead to a plethora of 
studies into its mode of action, structural modification, semi-synthesis, total synthesis and even commercial 
application.1 
Since 1951 seven semi-synthetic analogues have made it to late stage clinical trials: etoposide (9), 
teniposide(10), etopophos (currently in use1), NK-611 (12), GL331 (14), NPF (13), and TOP53 (15) 
(currently in clinical trials).1 Etoposide (aka Vepesid®, 9), its prodrug etopophos (11), and teniposide (10) 
are commercially used and approved by the FDA as anticancer agents (see Figure 5).6,36 Podophyllotoxin 
itself has also been commercially marketed under the names “Condoline” and “Warticon” as creams to treat 
genital warts.38 Furthermore, podophyllotoxin and its analogues have shown significant anti-cancer activity, 
however, this is not the full extent of its uses. Podophyllotoxin and its analogues have been approved as 
antivirals (mainly in treatment of the Human papilloma virus (HPV)), in dermatology (in the treatment of 
venereal warts), as vascular disrupting agents, and as an arthritis medication.27 Podophyllotoxin analogues 
have been extensively used to treat Wilms tumors, non-Hodgkin and other lymphomas, colon and lung 
cancer.17 Further research has also shown the best responses occurred when podophyllotoxins were used in 
combination with cisplatin.27 
(-)-Podophyllotoxin (1) shares a target site with colchicine, with both drugs inhibiting tubulin 
polymerization39 which affects the cell’s ability to divide, and thus induces apoptosis. Tubulin, an α-β 
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 28 
heterodimer, forms the core of microtubules, and is vital for mitosis. We now know that the affected cells 
enter mitosis, but cannot undergo chromosomal separation, leading to cell death.27,4 
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Figure 5: The structures of Etoposide (9), Teniposide (10), Etopophos (11), NK-611 (12), NFP 
(13), GL331 (14) and TOP53 (15) 
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Etoposide (9) has displayed bioactivity by acting as an irreversible topoisomerase II inhibitor. Cancer cells 
will in fact not even enter mitosis one hour after administration of the drug.27,5 Topoisomerase II is 
understood to interact with the supercoiled DNA double helix.6 By disrupting the action of topoisomerase, 
etoposide (9) prevents the DNA double helix from re-ligating after uncoiling during the mitotic stage, and 
interferes with the protein synthetic processes. Unable to re-form the DNA double helix, cell death is 
initiated. Podophyllotoxin (1) and etoposide (9) induce death of both cancer cells and healthy cells.39 They 
act as anti-cancer agents based on the principle that cancer cell metabolism is faster than that of healthy 
cells. This leads to inefficient treatment of the cancer due to the simultaneous death of normal and cancerous 
cells.5 Other antineoplastic mechanisms have also been reported for GL331(14), etoposide (9) and other 
analogues. These mechanisms have been attributed to the formation of radical species after the drug enters 
the cell. There have also been reports of interactions with tyrosine phosphate and several kinases.36 
Podophyllotoxin is classified as an aryltetralinlactone cyclolignan and is comprised of a flat ridged 
five ring system. This system contains four main points of stereoisomerism (C1-4 on ring C). There are 
many iterations of podophyllotoxin (see Figure 6) and its extracted analogues, including 
deoxpodophyllotoxin (hydrogen at C4 instead of alcohol), 4’-demethylpodophyllotoxin (phenolic group in 
para position on E ring, C19),  α-peltatin (alcohol functional group on B ring instead of C ring, C7) , β-
peltatin (alcohol functional group on B ring instead of C ring, C7, and phenolic moiety on C19) 
podophyllotoxone (aldehyde at C4).1 
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Ring A: Dioxolane ring A is essential for activity. Opening of the ring, or functionalization of the phenolic 
groups (12/13) has not shown improved cytotoxic activity.1 Research has also been done into replacement 
of Rings A and B to accommodate a naphthalene system.40 
Ring B: Though this ring does accept modification, modification has not shown improved activity against 
Topo II when compared to etoposide (e.g. α-peltatin & β-peltatin).36  
Ring C: This is the most modified ring. Nitrogen at C4 constitutes a 4-aza-podophyllotoxin. Note that in 
Figure 5 this position experiences the most variety, this is also seen in the naturally extracted compounds. 
The C1 position gives rise to diastereomers, these diastereomers show indistinguishable biological activity.1 
Ring D: The trans lactone ring D has been extensively modified with varying success, cis lactone, lactam, 
hydroxy acids and various heterocycles and open ring modification is occasionally accepted. Ring opening 
to hydroxy acid can occur in vivo leading to inactivation.1,36  
Ring E: These have experienced extensive modification; it should be noted that this ring need not be able 
to rotate. 
 
Figure 6: Generalized structure of podophyllotoxin and summary of the attempted modifications 
to the structure and corresponding biological activity changes.  
 
Ring C has been extensively 
modified and contains the most 
stereochemistry.  
Ring D is essential for biological 
activity, and is base sensitive, it 
need not be trans.  
Halogens at C2 show increased 
activity.  
Ring E: X and Y typically 
methoxy moieties. R2 shows 
etoposide activity when phenolic. 
Ring E has been heavily modified 
with success. 
Ring B: C7 can be modified (e.g. 
α-peltatin & β-peltatin), shows 
varying activity. 
Ring A: Dioxolane ring A is 
essential for biological activity, 
modification is not accepted. 
C4 position shows the most 
modification in literature, and can 
be modified to be nitrogen, or 
oxygen. 
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As can be seen in Figure 6, the most common point of modification is on the C4 position of the C 
ring. The C4 position has been modified in total synthesis to incorporate nitrogen or oxygen atoms in place 
of carbon at this position. It is also this position and the para position on the pendant E ring that have seen 
successful modification with corresponding activity changes (Figure 5). It has been postulated that the para 
position on the E ring may be responsible for mechanistic changes in biological activity.36 Before 2008 
there were four main methods used for synthesis of (-) podophyllotoxin, all of which showed low yields 
that lead to the continued use of the naturally extracted product for the synthesis of many analogues. The 
lack of synthetic options originates from the base sensitive tans lactone ring D. The synthesis of GL331 
was the first two-step one-pot reaction to afford produce drug from the natural product.41  
Despite the difficult of synthesising (-)-podophyllotoxin extensive research into podophyllotoxin 
and its analogues has been performed, therefore focus has been placed on the research into 4-aza-
podophyllotoxin analogues. Though both 4-aza and 4-oxy show significant loss of stereochemistry at the 
C4 position, several studies into the activity of these modified compounds have shown comparative acidity 
to natural podophyllotoxin and etoposide. It should be noted that the biological activity of the 4-aza-
podophylloptoxin was undertaken with racemic mixtures of the analogues. Natural podophyllotoxin and 
etoposide show IC50 values of between 0.076 and 0.05 µm against HeLa cell lines, which is similarly 
reported for the 4-aza-podophyllotoxin analogues.1 Detailed information on the various IC50 values have 
been reviewed by Yu et al.(2017).1 It should be noted that a significant research step was taken towards the 
total synthesis of (-)-podophyllotoxin and was undertaken in 2013 by Ishikawa and co-workers and consists 
of 10 steps.7 The most recent total synthesis of (-)-podophyllotoxin in six steps was performed by Renata 
and co-workers in 2019.42  
 4-Aza-podophylltoxin analogues 
The first reported total synthesis of 4-aza-podophyllotoxin analogues cannot be accurately traced, 
however, in 2000 Takeya and coworkers reported a three-step synthesis of two 4-aza-podophyllotoxin 
analogues, which was considered the most significant step towards short total synthesis. In 2002 a one-step, 
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one-pot-MCR was developed by Giorgi-Renault and coworkers.37 This reaction was done in ethanol using 
a functionalized aniline, tetronic acid and a functionalized benzaldehyde to provide the desired structure.  
Since the development of the MCR procedure in 2002, investigations into fast and simple synthesis 
of 4-aza-podophyllotoxin analogues have been undertaken. The mechanism for this reaction has been a 
topic of much debate, with the currently most accepted mechanism proposed by Jeedimalla et al.43 This 
depicted below in Scheme 1. 
 
Scheme 1: Scheme to show the mechanism proposed by Jeedimalla et al. in 2013.43 
The synthesis of 4-aza-podophylltoxin analogues can be divided into two parts, the first the 
formation of functionalized anilines, and the second the multi-component reaction. The 4-aza-
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podophylltoxin structure is formed through the formation of a Knoevenagel adduct (19), followed by the 
addition of tetronic acid (20), regenerating the aniline (17). The functionalised aniline (22) then undergoes 
1,2 addition to form a condensation product (24/25) that can then undergo ring formation to produce the 4-
aza-podophylltoxin (26). Jeedimalla et al. also propose the use of a sacrificial aniline, included here as 17, 
like p-chloro-aniline to increase yields of the desired analogue 26.43 There has recently been another 
extensive study of the mechanism which proposes that the exact equivalents of the starting materials used 
can have a major effect on the structure obtained.44 
There still exist a wide range of podophyllotoxin analogues that have yet to be explored. It is hoped 
that this project will help to take one step forward into the future of treating cancer and using our 
understanding of the natural world to do so.  
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Chapter 2: Results and Discussion 
2.1 Aims and Objectives 
This research had two key interests. The first was to synthesize the modified 4-aza-
podophyllotoxin-analogues (see Figure 7) through a set of multicomponent reactions to further investigate 
structure activity relationships. The second was to add biologically active moieties to the 4-N position that 
can selectively target cancer cells, or act as fluorescent markers. By achieving these two objectives cell 
apoptosis would hopefully be induced through selectively poisoning topoisomerase II and/or through 
tubulin inhibition by the 4-aza-podophylotoxin as discussed in Chapter 1.  
These aims were accomplished through the generation of a library of N-substituted anilines. The 
anilines were used in multicomponent reactions with functionalized benzaldehydes and tetronic acid 
following the method proposed by Giorgi-Renault and co-workers in 2002.37 The functional groups were 
added with the intention of overcoming the problems experienced with previously tested 4-aza-
podophyllotoxins-analogues, i.e. severe gastrointestinal side effects and mild insolubility.45 The products 
synthesized were sent for biological activity testing, the results of which were to be used to motivate the 
synthesis of more selective podophyllotoxin-analogues. 
 
 
Figure 7: Generalized structure of the 4-aza-podophyllotoxin analogues synthesized in this project, 
where R1 is a series of alkyl groups and R2 consists of either a phenolic or methoxy moiety. 
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The research was undertaken in two parts resulting in: Library 1 and Library 2. Library 1 was 
synthesized with the goal of testing various modifications on the C4 position on the C ring (R1, Figure 7), 
as well as modifications to the lower E ring, specifically to R2 (Figure 7). Library 2 was synthesized with 
the intention of further modifying the R1 position of compounds synthesized in Library 1. This was achieved 
by using click chemistry on compounds 36a and 36b. Twelve final compounds were synthesized and 
isolated in Library 1 and a further four in Library 2. Biological data obtained from testing compounds in 
Library 1 (see Chapter 4) was used to inform the synthesis of Library 2. 
This chapter will first provide details of the syntheses undertaken. The synthesis of Library 1 is 
described, starting with the synthesis of N-functionalized anilines, followed by the synthesis of 4N-
functionlized-aza-podophyllotoxins, and finally the synthesis of modified compounds from Library 1. 
Library 2 is then discussed. Library 2 was synthesized from products found in Library 1 and a set of azides. 
The section discussing Library 2 begins with the synthesis of the azides and ends with the 4-aza-
podophyllotoxin click reaction products.  
 
2.2 Synthesis of Library 1: modification of the 4N-position through the synthesis of N-functionalized 
anilines  
The choice of which 4-aza-podophyllotoxin analogues to synthesise for Library 1 was motivated 
by four factors. First, the 4-aza-podophyllotoxins that were synthesised needed to have potential for further 
modification on the 4-N position. Second, the analogues needed to have the ability to mimic 
podophyllotoxin analogues that act as topoisomerase II poisons, currently in chemical trials or in use, 
specifically etoposide and GL-331, through the lower E ring substitution and 4N-substitution. Third, the N 
functionalized anilines should not interfere with the MCR. Finally, the 4-aza-podophylltoxin analogues 
generated needed to be sufficiently dissimilar in the 4-N and R2 positions to generate a structure activity 
relationship. 
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 Synthesis of anilines for MCR in Library 1 
The main starting material chosen for this project was 3,4-(methylenedioxy)aniline as it forms the A, B and 
part of the C rings (see Figure 7). The following anilines were synthesized in yields sufficient for synthesis 
of the desired 4-aza-podophyllotoxin analogues: 
 
Figure 8: Starting materials (SM) used in the synthesis of the 4-aza-podophylltoxin analogues. 
 
 
Figure 9: Functionalized anilines synthesized from 3,4-(methylenedioxy)aniline. 
Ethyl benzo[d][1,3]dioxol-5-ylglycinate (27) was successfully synthesized, by heating for 96 hours at 66 °C 
in THF, using ethyl chloroacetate and K2CO3, affording the product in a 51% yield. K2CO3 was chosen 
instead of a stronger base, as its use decreased the potential for bis-alkylation. Ethanol was initially used as 
solvent but afforded a much lower yield (17%). This was most likely due to hydrogen bonding interference, 
between the ethanol and the amine nucleophile during the reaction (bis-functionalization was observed in 
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the minor product). Options other than the classical SN2 strategy, such as protection and then deprotection 
of the primary amine, or use of reductive amination, would be inefficient. Protection and deprotection could 
only yield the product over three steps, instead of one as displayed here (see Scheme 2). Reductive 
amination would have resulted in multiple side-products. Protecting groups would have led to longer, 
inefficient reaction schemes.  
The 1H NMR spectrum for compound 27 showed the appearance of a new triplet peak at 1.28 ppm, 
a singlet peak at 3.83 ppm and quaternary peak at 4.23 ppm, not present in the spectra of the starting material 
(SM1), indicating that compound 27 was synthesized. In addition, MS data showed a dominant peak at 
224.09 m/z as expected. 
 
Scheme 2: synthesis of methyl ester functionalized aniline 
Table 1  shows how the optimization of the synthesis of compound 27 was achieved. As can be 
seen in the table, reactions 1and 3, in ethanol, afforded significantly lower yields than those performed in 
THF. It was clear that increased reaction times led to increased yield for the first 72 hours (48%, reaction 
4, Table 1). After that increasing reaction times did not lead to a significant increase in yield. After 96 
hours (reaction 5, Table 1) an increased yield of only 3%, to 51% was observed. Sufficient amounts of the 
desired product had then been synthesized and further optimizations for this reaction were not performed. 
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Table 1: Reaction conditions for achieving the optimization of production of compound 27 
Reaction number Time in hours Temperature in °C Solvent used Percentage yield 
In % 
1 24 80 EtOH 10 
2 24 66 THF 32 
3 48 25 EtOH 5 
4 72 66 THF 48 
5 96 66 THF 51 
 
Synthesis of ethyl 3-(benzo[d][1,3]dioxol-5-ylamino) propanoate (28) was accomplished through 
a Michael addition (1,4-conjugate addition) between ethyl acrylate and 3,4-(methylenedioxy)aniline (SM1). 
Initially the synthesis proved challenging, with several catalysts having been employed (reactions 1 and 2, 
Table 2). These reactions were based on using Cu(I), and Fe(II) complex formation.46 However, the use of 
these catalysts proved unsuccessful in providing significant yields. This was likely due to the auto-
polymerization of ethyl acrylate in the absence of a radical scavenger; however, this was not investigated. 
At first compound 28 was synthesized  by the author, through a neat reaction between the two compounds 
under microwave irradiation (reactions 3 and 4, Table 2).47,48 The use of the neat reaction, though unusual, 
has been used in reactions between amines and α,β-conjugated carbonyl compounds and is discussed in-
depth by Ranu et al.,47 due to the environmentally friendly nature of the reaction when applied. The solvent-
free methods allowed for the formation of the desired final product 28, with yields ranging from 17  ̶26% 
(Table 2 reactions 4 and 5). The use of microwave heating in 1,4-conjugate addition is discussed by 
Escalante et al.,48 in which primary amines were successfully reacted with methyl acrylates in methanol. It 
is well known that microwave irradiation (MWI) offers various benefits in organic synthesis, such as faster 
reaction times and accommodating milder reaction conditions than conventional heating methods.49 The 
SN2 strategy was also employed using ethyl-2-bromo-ethanoate however the final yield of 28 was found to 
be only 22%, as shown in Table 2, reaction 8, the low yield can be attributed to bis-alkylation of the product, 
however this was not thoroughly investigated. 
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Product 28 was best produced under conventional heating at 60 °C for 72 hours, without solvent, 
following the method proposed by Ranu, Dey, and Hajra in 2002 (see Scheme 3).47,50 This yielded the 
product in 56% yield (Table 2 reaction 7). The structure was confirmed using analytical techniques such 
as 1H NMR spectroscopic analysis, with the appearance of peaks at 4.15, 3.37, 2.58 and 1.26 ppm, 
accounting for the ester moiety which corresponded well with the literature.51 In addition, mass 
spectroscopy showed an m/z value of 238.1071, where the expected exact mass (calculated M+H) for the 
compound is 238.1079. 
 
Scheme 3: Synthesis of ethyl ester functionalized aniline 







Solvent Catalyst Percentage yield 
in % 
1 40 40 DCM FeCl2 & NaH 0 
2 96 25 Toluene Cu(I)Cl, PPh3, 
KOtBu 
0 





4 3 80 neat Microwave 
Irradiation 
17 
5 24 25 None None 26 
6 27 58 None None 22 
7 72 60 None None 56 
8 96 66 THF None 22 
 
The addition of the alkynyl functional group to form compound 29 was achieved with the best yield 
of 72% by reacting propargyl bromide and 3,4-(methylenedioxy)aniline in DMF with K2CO3 at a 
temperature of 90 °C for 2 hours (Table 3 entry 3, Scheme 4). Table 3 details the optimizations performed 
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to obtain product 29 with a maximum yield of 72%. HRMS showed the presence of peaks at m/z 176.706 
where the calculated expected M+H value was 176.0712. The 1H NMR spectrum of the minor product (see 
Supplementary information) showed peak integrations twice that of the major product for the propargyl 
moiety at 2.22 ppm and 3.87 ppm, indicating the presence of a tertiary amine due to bis-alkylation of SM1, 
accounting for the lost yield (20% approximate yield of minor product). Acetonitrile was attempted as a 
solvent, however, this produced significantly lower yields (15 and 44%), under the same conditions in DMF 
(Table 3, entries 1 and 4).  
 
Scheme 4: Synthesis of propyne functionalized aniline 
Table 3: Reaction conditions for achieving the optimization of production of compound 29 
Reaction number Time in hours Temperature in °C Solvent Percentage yield 
in % 
1 0,5 82 Acetonitrile 15 
2 2 25 DMF 18 
3 2 90 DMF 72 
4 2 90 Acetonitrile 44 
5 6 25 DMF 49 
6 24 25 THF 24 
 
 
Scheme 5: Synthesis of para-nitrobenzene functionalized aniline (30) 
Compounds 30 (para-nitrobenzene functionalized, Scheme 5) and 31 (meta-nitrobenzene 
functionalized) were successfully synthesized in significant yields using reductive amination between 3,4-
(methylenedioxy)aniline and a nitro benzaldehyde. Products 30 and 31 were optimally produced in 61% 
and 70% yield respectively (reaction 9, Table 4). The synthesis of compound 30, was also achieved using 
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an SN2 approach. 3,4-(Methylenedioxy)aniline (SM1) and 4-nitrobenzyl bromide were reacted, and  
produced the desired product (reactions 3,4 and 5, Table 4). The yields obtained using this approach were 
significantly lower, with the best being 30%. It is proposed that this is likely due to the formation of the 
bis-alkylated product as suggested by 1H NMR spectroscopy (see Supplementary information).  
The 1H NMR spectra showed the appearance of peaks in the aromatic range, as well as at 4.40 ppm 
for 30 and 4.38 ppm for 31, in addition IR spectroscopy also showed peaks in the 1450-1550 cm-1 range 
indicative of the aromatic NO bond. Formation of products 30 and 31 was accomplished in the highest 
yields after 36 hours by in situ formation of selective reducing agent Zn(BH4)2 using ZnBr2 and NaBH4 in 
acetonitrile. THF was also used as solvent but resulted in significantly lower yields for 30 (16%, reaction 
8, Table 4). Other methods of reductive amination, such as using only NaBH4 or zinc powder and KOH 
were also attempted. The yields for these were significantly lower (all below 30% yield, reactions 6 and 7, 
Table 4).52,53 
 







Solvent Reagent Percentage yield 
in % 
1 24 100 Acetonitrile K2CO3 0 
2 24 65 THF K2CO3 0 
3 6 100 Toluene K2CO3 5 
4 24 65 Acetonitrile K2CO3 10 
5 24 100 Toluene K2CO3 30 
6 24 25 H2O:MeOH KOH, Zinc powder 15 
7 24 25 THF NaBH4 28 
8 36 25 THF ZnBr2, NaBH4 16 
9 36 25 Acetonitrile ZnBr2, NaBH4 61 
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Scheme 6: The synthesis of product 32 using di-tosylated propanolamine. 
The attempted synthesis of compound 32 was done over two steps (see Scheme 6), with the goal 
that the final MCR product would then be deprotected and used in amide, amino acid or other nucleophilic 
couplings. The first step was the synthesis of 3-(4-methylphenylsulfonamido) propyl 4-
methylbenzenesulfonate in 22% yield from propanolamine. This was accomplished by reacting two 
equivalents of tosyl chloride with propanolamine in DCM with triethylamine as base. The presence of di-
tosylated propanolamine was confirmed by HRMS due to the existence of peaks at m/z 383.0932, where 
the calculated m/z for M+H is 384.3909. The 1H NMR spectrum corresponded with values given in 
literature.54 Cherepakhin et al. mention that the formation of the di-tosylated propanolamine can result in a 
ring closure reaction to form a 4-membered ring. Fortunately, this ring is still susceptible to ring opening 
through an SN2 reaction, allowing the formation of the desired tosylated product. 
The product was then reacted with 3,4-(methylenedioxy) aniline and potassium carbonate in DCM 
at room temperature for 12 hours to yield product 32 with a disappointing 8% overall yield. A TLC of the 
crude product showed the presence of a significant number of unidentified products. Although product 32 
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 Synthesis of 4-aza-podophyllotoxin analogues for Library 1 
Upon successful synthesis of the N-functionalized anilines (27-32), synthesis of compounds 33-39 
was attempted using the MCR procedure published by Giorgi-Renault et al. (see Scheme 7).37 This involved 
reacting an N-functionalized aniline with tetronic acid and a functionalized benzaldehyde in ethanol. In this 
case, N-functionalized 3,4-(methylenedioxy)aniline, tetronic acid and either syringaldehyde (for all A 
labeled compounds) or 1,2,3-trimethoxybenzaldahyde (used for compounds B). To accommodate 
microwave irradiation (MWI), for faster and shorter reaction times, ethylene glycol was used as a solvent 
instead of ethanol. Typically ethanol is used (boiling point 78 oC), as proposed by Giorgi-Renault et al.55 
Ethyleneglycol was used for the microwave reactions due to its higher boiling point (197.3 oC) to prevent 
pressure buildup. In addition 4-chloroaniline was used as a sacrificial aniline, as published by Jeedimalla 
et al.43 4-chloroaniline has a much lower electron-donating ability when compared to 3,4-
(methylenedioxy)aniline (SM1) and during the reaction 4-chloroaniline was replaced by the required 
functionalized aniline after Knoevenagel condensation (see 22 in Chapter 1, Scheme 1, for more details 
about this mechanism). 
As has been discussed in Chapter 1, during the formation of the 4-aza-podophylltoxin analogues, 
there is no control of stereochemical elements in the C ring, resulting in two enantiomers being formed 
(relative to the C1 position). Recent research has been done into increasing enantiomeric selectivity during 
the MCR; however, little to no enantiomeric excess has been observed ( 24 and 25, Scheme 1, Chapter 
1),43 therefore, the general biological data for these compounds represent that of a racemic mixture.8 Though 
the enantiomers are not expected to share identical biological activity the initial testing was performed on 
the enantiomeric mixture. The idea was that if a racemic mixture was found to be significantly active, 
further efforts could be focused on testing of the individual enantiomers. 1  
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Scheme 7: The compounds attempted for the synthesis of Library 1, for biological testing 
 Compound 33: 4N-analogue modified by the addition of methyl ethanoate 
 
Figure 10: Structures of methyl ester4N-functionalised compounds 33a and 33b 
Synthesis of compound 33 using MWI and sacrificial aniline 4-chloroaniline led to higher yields 
(44% for compound 33a, m/z: 470.1446, M+H calculated to be 470.1451 m/z) when compared to the yield 
of the catalyst-free reaction (26% for compound 33a). Conventional heating of the reaction led to a 
significantly lower yield of <5% (for compound 33a), when run for the same time. The successful synthesis 
of compounds 33a and 33b, (35% yield for 33b, m/z: 484.1602, calculated to be 484.1608 m/z) was achieved 
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and confirmed by IR, MS and NMR spectroscopic analysis. The 1H NMR spectroscopic analysis of 33a 
showed a triplet peak at 1.24 ppm, indicative of the methyl carbons on the ester moiety (from 27), as well 
as a peak at 3.13 ppm, which indicated the presence of the methoxy functional groups on syringaldehyde 
(SM3). A signal at 4.78 ppm was also observed, corresponding to the D ring CH2 group (from tetronic acid, 
SM2). Similar peaks were observed for 33b, though integration of peaks at 3.13 showed 9 protons 
corresponding to 1,2,3-trimethoxybenzaldehyde (SM3). 
Like compound 33a, 33b was successfully synthesized in 35% yield using the method proposed 
for 33a. Of note was that when halving reaction times to only 1 hour under MWI, only 17% yield was 
achieved for compound 33b. 
 Compound 34: 4N-analogue modified by the addition of ethyl ethanoate 
 
Figure 11: Structures of ethyl ester 4N-functionalized compounds 34a and 34b 
Compound 34a was only achieved in 8% yield (HRMS: calculated (M+H) 484.16 m/z, found peak 
at 484.1596 m/z) using the method used for 33a and 33b. This led to experimentation with lower 
temperatures and shortened reaction times (110°C for 35 minutes). However, the largest yield obtained, 8%, 
was still obtained under MWI, with the sacrificial aniline, at 180 °C for 2 hours. In addition, compound 34b 
(HRMS: calculated (M+H) 496.1608; found peak at 496.1609 m/z.) was obtained in a similarly 
disappointing 14% yield under the same conditions. We propose that the low yields obtained can be 
attributed to reactions with the ester moiety, either through the formation of an amide to replace the ester 
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or through unwanted ring closure, through the Skraup reaction, however this remains speculation.56 The 
longer chain ester is also more reactive than its short chain counterpart (27 and 33a/b). This is due to its 
ability to more easily form the enolate isomer due to the lower pKa of the proton’s alpha to the carbonyl 
moiety, and increased stability due to the inductive effect.57  
The increased potential to form minor products may have impacted the yields obtained. Similar 
peaks were observed in the 1H NMR spectrum as for those of 33a/b; however, extra peaks were observed 
in the 1.28-1.13 ppm range, for 34b, corresponding to the peaks expected for the longer carbon chain in the 
4N position. It was suspected that the missing peaks in the 1H NMR spectrum for 34a was due to the 
previously proposed enolization of the ester functional group.  
 Compound 35: 4-N analogue modified with tosyl protected amine 
Synthesis of compound 35a/b was unfortunately not achieved. 1H NMR spectroscopy showed the 
presence of the peaks corresponding to the tosyl protected amine; however, mass spectroscopy showed 
masses inconsistent with the expected product. It is proposed that the tosylated amine was still reactive 
enough to inhibit the formation of the desired product during the multicomponent reaction, instead forming 
undesired side products. Mass spectroscopy also indicated the formation of minor products with compound 
35a showing a m/z of 585 and 501, where the calculated expected M+H value was 594 m/z. Compound 35b 
showed the appearance of peaks at 455 and 587 m/z, while the calculated expected value was 609 m/z. This 
indicates that the final desired ring closure did not take place. Further optimization of the synthesis of 
compound 32 will need to be performed before further attempts at synthesis can be made. It was hoped that 
if synthesis was successful the amine could be deprotected under mild conditions and low temperatures and 
then used as a nucleophile in other coupling reactions. 
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 Compound 36-4N analogue modified with propyne moiety 
 
Figure 12: Structures of propyne 4N-functionlized compounds 36a and 36b 
Compounds 36a and 36b were produced in 32% and 66% yields respectively. The synthesis of 
compound 36a was attempted multiple times, with the best yield of 32% being obtained under MWI at 
110°C for 7 minutes and 30 seconds. Mass spectroscopy of 36a revealed a m/z value of 422.1238 m/z while 
the calculated value for 36a was at 422.1240 m/z. On the other hand, 36b was obtained after 10 minutes at 
150°C under MWI. Mass spectroscopy found the relevant peak corresponding to 36b at 436.1382 m/z which 
correlates well with the expected calculated value (M+H), which was 436.1396 m/z. The reasons for the 
differences in yield remain unclear and have not been explored further in this research project. Products 
36a and 36b both showed the presence of peaks corresponding to the propargyl-moiety between 3.80 and 
4.20 ppm in the 1H NMR spectrum. IR spectroscopy also showed the appearance of a broad peak in the 
1250-1450 cm-1 range, indicative of the alkyne functional group.  
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 Compound 37: 4N-analogue modified with para-nitrobenzene 
 
Figure 13: Structures of para-nitrobenzene functionalized compounds 37a and 37b 
Synthesis of compounds 37a and 37b were achieved in 61% and 15% yield respectively. Upon 
heating under MWI, compounds 37a and 37b were not observed, however, under conventional heating to 
198°C for 30s both products were obtained. It is proposed that the electron-withdrawing effect from the 
nitro group on compound 30 may have influenced the reaction, by improving the reactivity of the amine. 
For compound 37a a calculated mass (M+H) of 519.1404 m/z was expected, while experimentally using 
HRMS a value of 519.1406 m/z was obtained. For compound 37b the HRMS expected a calculated m/z 
(M+H) of 533.1560, a molecular peak was observed at 533.1594 m/z. IR spectroscopy also showed peaks 
in the 1450-1550 cm-1 range, indicative of the aromatic NO2 group. Proton NMR spectroscopy also showed 
the appearance of new peaks in the aromatic region when compared to 33a and 33b. 
 
 Compound 38: unfunctionalized 4N-aza-podophyllotin analogues  
Both compounds 38a and 38b were obtained after 10 minutes under MWI at 150 °C; compound 
38a finally, with 43% yield and compound 38b with a 28% yield. Both compounds 38a and 38b showed 
little formation under higher temperatures or longer reaction times; instead forming what was suspected to 
be mixtures of polymers. No additional analysis was performed on this product, and it was not further 
investigated. When attempted at lower temperatures no yield was observed for both 38a and 38b. The mass 
spectrum for 38a showed the presence of a large peak at 382.0922 m/z (M+H) and a smaller signal at 
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384.1069, compared to the calculated expected mass which should be 384.0888 m/z. This indicated the 
molecular formula to be C20H16NO7; however, this and NMR spectroscopy did not correlate with literature 
reported values. The 1H NMR spectrum obtained indicated the absence of two peaks, correlating with the 
missing hydrogen atoms expected for an oxidation product.37 They both indicated the loss of 2 protons 
relative to the initially reported structure, most likely due to the oxidation of the product (see Figure 14). 
The mass spectrum for 38b shows peaks for C21H20NO7, 398.1236 m/z, while the calculated mass (M+H) 
was 398.1240 m/z, which is consistent with literature.37 Despite 38a not corresponding to literature reported 
values, the biological testing of compounds 38a and 38b correlated well with the expected values and 
showed potencies higher than the other compounds synthesized in Library 1. 
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 Hydrolysis of compounds 33a and 33b 
In order to test the availability of the synthesized esters (33a and 33b) for further modification, 
without the disruption of the overall structure, hydrolysis of the desired esters was attempted under basic 
conditions. This was chosen because of the sensitive nature of the lactone ring (D ring, Figure 7).36  
The successful synthesis of compounds 33a and 33b allowed for the attempted hydrolysis of the 
compounds, to produce 39a and 39b. Hydrolysis was attempted by reacting 33a and 33b separately, with 








Scheme 8: Hydrolysis of esters 33a and 33b to carboxylic acids 39a and 39b with base. 
Both MS and IR as well as 1H NMR spectroscopy show the formation of the hydrolyzed forms of 
33a and 33b, i.e. 39a and 39b. LCMS, however, showed <50% purity of the compounds. Unfortunately 
attempts at separation failed. Even after ethanol recrystallization or flash column chromatography TLC 
analysis showed the presence of starting material 33a or 33b. For the latter method the starting materials 
appeared to elute at similar times to 39a or 39b. It is suspected that ring opening occurred at D ring due to 
LiOH resulting in minor products (see discussion in Chapter 1, Figure 6).58 However for the most part, 
these conditions were mild enough to hydrolyze the ester without excessive hydrolysis of the lactone group 
present on the molecule.59 To be clear, the desired reaction took place, despite the formation of small 
amounts of the minor product. Yields of the crude mixtures of 99% (39a in 68% purity) and 43% (39b, 
crude <50% purity) were achieved respectively. 
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1H NMR spectroscopic analysis suggested conversion to the acidic form of the 4-aza-
podophyllotoxin (39a and 39b) was successful; despite the presence of some starting material. LCMS 
analysis showed the presence of both 33a/b and 39a/b in the crude product obtained. Further purification 
is however required. This could be accomplished through HPLC, as flash column chromatography of these 
compounds has not been sufficient for purification.  
In terms of spectral analysis, the crude mixture containing compound 39a showed a major peak 
present at m/z, 442.1142, where the calculated expected mass (M+H) was 442.1138 m/z. Compound 39b 
showed a m/z peak at 456.1276 (corresponding to the calculated expected value of.456.1276 m/z). Staining 
with Bromocresol green, as well as IR spectroscopy confirmed the presence of the acidic form of the desired 
compounds (39a and 39b). IR spectroscopy showed the appearance of broad, intense bands in the OH 
region (2500-3700) of the spectra, that was not apparent in the spectra for compounds 33a and 33b.60 
 
2.3 Synthesis of Library 2: 4-aza-podophyllotoxin analogues synthesized through copper mediated 
alkyne azide cycloadditions 
With the information gathered from Library 1, as well as the biological results (discussed in 
Chapter 4), the synthesis of Library 2 proceeded with the intent to further modify products 36a and 36b. 
The choice was motivated by both their significant biological activity (IC50 =  <275 nM), 1 as well as their 
ability to be further modified in the absence of acidic conditions, specifically their potential to undergo 
‘Click’ chemistry.61 The use of a copper-mediated azide alkyne cycloaddition (CuAAC), was further 
motivated by its potential to introduce more nitrogen atoms into the analogue scaffold. It should also be 
noted that GL331 (14) has a nitrogen atom in the α position when compared to the podophyllotoxin scaffold. 
It is proposed that this may improve its selectivity to cancer cells.1  
The incorporation of a triazole ring may further improve selectivity, as well as biological activity, 
despite the increased molecular weight. This increase in weight may prevent the crossing of the analogue 
over the cellular membrane;20 however, the cancer cells increased need for nitrogen for metabolic activity 
may overcome this. Copper-mediated click chemistry also shows great selectivity, specifically in generating 
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 52 
the 1,4-triazole, instead of the 1,5 triazole.62 The synthesis of azides, shown in Figure 15, was attempted in 
preparation for the synthesis of the compounds in Library 2,with 4 out of the 5 syntheses being successful.  
 
 
Figure 15: Desired azides for use in click reactions  
Each compound was chosen for their individual characteristics. Compounds 40 and 41, were chosen 
because they can act as fluorescent probes for the observation of the movement of the 4-aza-
podophyllotoxin analogues in vitro. They were also chosen with different lengths of the carbon chains to 
determine if the dansyl azide affects biological activity, as well as the steric and free rotating implications 
of the chain length when in the cell. Compound 42 was picked to determine if the incorporation of amino 
acids into the cancer cell would improve biological activity. Azides 43 and 44 were chosen to provide a 
basis of comparison with 45, as well as for their potential to further form benzoic esters if desired. 
Compound 45 was selected to compare with the clinically reviewed GL-331 (14), as well as with 
compounds 37a and 37b. The following section provides a discussion on the synthesis of the desired azides, 
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 Synthesis of azides 40-45 
Compound 40 was produced over three steps from commercially available dansyl chloride 46. This 
was achieved by first synthesizing compound 47, then 48, to finally yield 40. Compound 47 was synthesized 
by reacting ethanolamine, commercially available dansyl chloride 46 and triethylamine in DCM at 0°C for 
1 hour, yielding 47 in 93%. Compound 48 then had to be synthesized, and was produced in 31% yield using 
an Appel reaction.63 This was accomplished using product 47, tetrabromomethane, triphenyl phosphine and 
DCM at 0 °C. Product 48 was formed after 2.5 hours, as per TLC, before isolation using flash column 
chromatography with DCM:methanol as solvent.  
Finally, the synthesis of 40 was performed using sodium azide, dansyl ethyl bromide 4), in DMF 
at room temperature. Product 40 was obtained after 1 hour in 97% yield from 48, but with an overall yield 
of 28% after all three steps. This was confirmed by mass spectroscopy that presented a signal at 320.1173 
m/z which compared well with the calculated mass of 40 (M+H) 320.1181 m/z. Furthermore proton NMR 
spectroscopy and MS data correlated with literature reported values. 64 
 
Scheme 9: The synthesis of 40 from dansyl chloride 46 
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The synthesis of compound 41 was attempted in a very similar fashion. Using propanolamine, 
triethylamine, and dansyl chloride in DCM at 0°C, compound 49 was synthesized in 56% yield after 1 hour 
using the SN2 approach. The low yield might be consequence of the reaction of the alcohol functional group 
with the sulfonyl chloride instead of the amine, despite the greater stability of the sulfonamide functional 
group over the sulphonyl acid ester. It is suspected that this occurred despite the greater nucleophilicity of 
the nitrogen lone pair over those of oxygen. The difference in yield for 47 compared to 48 is unfortunately 
unclear. A modified Appel reaction was employed to convert the primary alcohol on 49 to the iodo moiety 
on 50. This was achieved in 93% yield using triphenyl phosphine, imidazole and iodine in DCM at 0°C for 
1hour, this method will be used for future synthesis of compound 48 due to its improved yields when 
compared to the synthesis of 50. The product, 50, was then converted into an azide using sodium azide as 
a nucleophile in DMF at room temperature. This yielded product 41 with 100% yield after 5 hours, but with 
an overall yield of 51% over all three steps. IR spectroscopic data showed the presence of peaks in the 
2050-2100 cm-1 range indicative of an azide. This product was also confirmed by comparison of the 1H 
NMR spectrum with that reported in lterature.64  
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Scheme 10: Synthesis of dansyl azide 41 from dansyl chloride 46.  
The attempted synthesis of Boc-protected phenyl alanine azide, 42, was performed in two parts. 
First the synthesis to produce the Boc-protected L-phenylalanine using L-phenylalanine, di-tert-butyl 
dicarbonate, and sodium hydroxide in water and THF was performed. This achieved the Boc protected 
amino acid in 87% yield. Mass spectroscopy was used to determine the mass-to-charge ratio of the 
intermediate. The expected mass (M+H) was calculated to be 266.1392 m/z, which correlated well with the 
signal in the mass spectrum at 266.1385 m/z. The synthesis of 42 was attempted reacting 2-azidoethyl 
methyl sulfonate, sodium hydride, the previously made Boc-protected amino acid and DMF at room 
temperature. However, the L-phenylalanine Boc protected azide was not produced after 24 hours. The 
absence of the final product was confirmed using the 1H NMR and mass spectrum, which did not correlate 
with literature data.65  
Compounds 43 and 44 were produced by a member of the synthetic chemistry group at Stellenbosch 
University (Mr. M.G. Botes) and utilized as is.  
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 56 
Finally, product 45 was synthesized by reacting sodium azide in DMF with 4-nitrobenzyl bromide 
for 5 hours at room temperature, producing product 45 in a yield of 95%. This product was confirmed by 
1H NMR spectroscopy which corresponded exactly to literature values.66 At the time of writing further 
confirmation by mass spectroscopy was awaited.  
 
 Click reactions 
Literature discussing copper-mediated azide-alkyne cycloadditions on podophyllotoxin scaffolds 
typically reports the use of azides in the α or β position to the C4 carbon, and reacting them with 
functionalized alkynes.61 Due to the restriction of using a nitrogen atom in the C4 position, as seen in 4-
aza-podophylltoxin analogues, it was necessary to take a unique approach resulting in the use of an alkyne 
in the 4N-position. This approach was not entirely successful. Although four of the ten desired compounds 
were synthesized (see Figure 16), synthesis required extensive optimization and extensive purification. 
In order to synthesize compounds 51-56 from products 36a and 36b, as shown in Figure 12, several 
methods were employed, based on the work of Sharpless et al.(see Scheme 11).67 For all syntheses copper 
acetate and copper sulfate were chosen as the starting point for generating the Cu(I) catalyst in situ.62 They 
were chosen for their potential to be reduced by weak reducing agents such as sodium L-ascorbate. In 
principle, click reactions can be performed without the need to employ a copper catalyst. However in efforts 
to selectively synthesize the 1,4-click products, no catalysis-free click reactions were attempted.67  
 
Scheme 11: General method of synthesis of alkyne azide cycloaddition products 
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Figure 16: 4-Aza-podophylltoxin analogues attempted through click chemistry of azides 40-45 
(excluding 42) with 4-aza-podophylltoxin derivatives 36a an 36b.  
 
Initially the synthesis of click products 52-56 (Figure 16) were attempted by mixing 36a or 36b 
with the corresponding azide, a copper catalyst, and sodium ascorbate in various solvents for several hours. 
Water was used to force the precipitation of the resultant product. Upon analysis of the residues formed for 
compounds 53a, 53b, 54b, and 55b using 1H NMR spectroscopy, it was concluded that no product 
formation had occurred. For these compounds only the initial 4-aza-podophylltoxin analogues 36a and 36b 
were recovered and little to no formation of the desired product was observed (<5%) as per the 1H NMR 
spectra. This may be as a result of solubility issues of compounds 36a and 36b. A series of tables can be 
found in the experimental section (Tables 10-13, Chapter 3) illustrating the synthetic methods attempted 
for these compounds. This section below discusses the synthesis, in numerical order, from product 52-55. 
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Figure 17: Expected structure of compound 52 synthesized from 36a/b and Azide 40. 
Several methods were attempted for the syntheses of compounds 52a (reactions 1-6 and 13 in Table 
5) and 52b (reactions 7-12 and 14 in Table 5). A variety of solvents (DMSO, tBuOH:H2O, DMF, and 
DCM:H2O) were used in the synthesis of 52a, in an attempt to improve yield (see reactions 1,2,3 and 5, 
Table 5). However, after several attempts, little to no final product formation was observed in the 1H NMR 
spectra. Attempts were then made at altering the Cu(I) catalyst, from copper acetate to copper sulfate. 
Unfortunately, no change was observed, and yields did not improve. Subsequently the amount of sodium 
L-ascorbate  used and temperature were increased, resulting in a very slight increase of yield (reaction 6, 
Table 5), potentially due to  the increased amount of Cu(I) present.68 The decision was then made to employ 
the Cu(I) stabilizing ligand THPTA. THPTA effectively increases the concentration of Cu(I) in solution 
and thus acts as a click accelerator. It is most commonly used in bioconjugation as it can prevent the 
oxidation of histidine and other molecules sensitive to peroxides and radicals formed from the copper 
catalyst.69  
Compound 52a was then successfully synthesized in 55% crude yield by adding ligand THPTA, 
using the reaction conditions specified in Table 5 reaction 13 (indicated with an asterisk (*))69.The presence 
of 52a was proved through the disappearance of alkynyl peak in the 1H NMR spectrum and the appearance 
of the aromatic, and triazole, peaks corresponding to the fluorescent moiety, 40. This was verified by the 
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appearance of a peak at 741.2325 m/z in the mass spectrum where the calculated expected value for M+H 
was 741.2343 m/z. Unfortunately, the starting material and a 2M+H peak representing THPTA were also 
observed in the mass spectrum for the final product. The product therefore requires further purification 
before it can be sent for biological testing. 
The use of THPTA and alteration of other reaction conditions did not increase the yields for product 
52b. This may be due to a difference in solubility between those compounds with the phenolic functional 
group compared to those with the methoxy functional group in the R2 position (see Figure 17). Although 
the mass spectrum did show the appearance of a signal at 745.2467 m/z which corresponds to the expected 
calculated mass of 745.2264, the 1H NMR spectrum did not show sufficient presence of the product. Minor 
peaks were observed in the higher aromatic range (upwards of 7.0 ppm) however those peaks did not offer 
conclusive evidence for the formation of product 52b.  
 
















1 52a DMSO 24 RT Cu(OAc)2 0.1 <5% 
2 52a DMF 24 RT Cu(OAc)2 0.1 <5% 
3 52a t-Bu:H2O 24 RT Cu(OAc)2 0.1 <5% 
4 52a t-Bu:H2O 24 RT Cu(SO4)∙5H2O  0.1 <5% 
5 52a DCM:H2O 6 RT Cu(SO4)∙5H2O  0,1 <5% 
6 52a DMSO 24 60 Cu(OAc)2 0.3 <10% 
7 52b DMSO 24 RT Cu(OAc)2 0.1 <5% 
8 52b DMSO 32 RT Cu(OAc)2 0.1 <5% 
9 52b DMSO 12 RT Cu(SO4)∙5H2O 0.1 <5% 
10 52b DMF 24 RT Cu(SO4)∙5H2O 0.1 <5% 
11 52b DCM:H2O 6 RT Cu(OAc)2 0,1 <5% 
12 52b DMSO 24 60 Cu(OAc)2 0.3 <5% 
13 52a* DMSO 24 RT Cu(SO4)∙5H2O 0.2 55 
14 52b* DMSO 24 RT Cu(SO4)∙5H2O  0.2 <5% 
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Figure 18: Structures of compounds 54 and 55 synthesized from 36a/b and azides 43 and 44. 
Product 54a (see Figure 18) was successfully synthesized a yield of 68% with a purity of 96% 
(LCMS), by heating compound 36a and azide 43 to 60 °C in the presence of sodium ascorbate (0.2 eq), 
copper acetate (10% w/w), and DMSO. 1H NMR spectroscopy confirms the formation of the desired 
product. The 1H NMR spectrum showed the appearance of peaks responsible for the benzylic acid in the 
8.4-7.1 ppm range. The mass spectrum also showed a m/z value of 599.1768 m/z, where the calculated 
expected value was 599.1778 m/z. Compound 54b was unfortunately not synthesized in sufficient quantities 
for further analysis.  For compounds 54 and 55 the amount of sodium ascorbate was altered first during 
optimization, as sodium ascorbate helps to buffer the reaction, as a reducing agent, lowering the chance of 
the benzylic acid affecting the overall podophyllotoxin scaffold. 
It was initially thought based on 1H NMR analysis, that compound 55a had been successfully 
synthesized in 65% yield. However, mass spectroscopy revealed a signal found at 583.1464 m/z and 
843.2399 m/z which did not correspond to the desired product or the starting materials, indicating the 
potential formation of a currently unidentified product. The difference in mass may indicate a loss of a 
methyl group (-CH3). The 1H NMR spectrum revealed peaks at 7.2-8.4 ppm that corresponded with the 
benzylic acid azide 44 as well as the peaks representing 36a. The reaction was performed by stirring azide 
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44, sodium l-ascorbate, copper sulfate, product 36a and ligand THPTA (55a*, reaction 7 in Table 6) in 
tert-butanol: water (1:1.3) for 24 hours at room temperature. 
Although the synthesis of 55b was attempted, no product formation was observed in either the mass 
spectrum or the 1H NMR spectrum. Multiple reaction conditions were tried (reactions 4-6, Table 6) but no 
yield of the final product was observed. This may again have been due to a solubility difference between 
36a and 36b. The mass spectrum of reaction 8 (Table 6) revealed that a mixture of starting materials were 
present in the mass spectrum. Peaks appeared at 871.2703 m/z, and 436.1391 m/z. This corresponded with 
THPTA (2M+H) and the starting material, compound 36b. The reason behind the lowwer yield for those 
analogues with a methyl functionality on the lower E ring is not yet clear, this may be due to solubility, but 
further exploration into this matter should be done in the future.  
















24h RT Cu(SO4)∙5H2O 0.3 <2 
3 55a DMSO 24h RT Cu(OAc)2 0.1 <2 
4 55b DMSO 24h 40 Cu(OAc)2 0.1 <2 
5 55b DMSO 24h RT Cu(OAc)2 0.3 <5 








24h RT Cu(SO4)∙5H2O 0.2 <10 
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Figure 19: Structure of product 56 from azide 45 and 4-aza-podophylltoixn derivatives 36a/b. 
Compounds 56a and 56b were successfully synthesized. Table 7 illustrates the improved yields of 
the synthesis of products 56a and 56b 97% and 65%, in DMSO vs that of t-BuOH:H2O. These reactions 
were performed in the presence of ligand THPTA. The improved yield can be attributed to the solubility of 
36a and 36b in DMSO when compared to tBuOH:H2O for the compounds 56a and 56b. Although the 
reaction was also attempted with Cu(OAc)2, the yields were significantly lower than those obtained with 
copper sulfate. The presence of 56a was confirmed by mass spectroscopy, where the calculated value for 
M+H was found to be 600.1731 m/z while a peak was found at 600.1743 m/z in the mass spectrum. The 
presence of compound 56b was also confirmed by mass spectroscopy where the expected M+H value of 
614.1887 m/z while a signal was found at 614.1883 m/z in the spectrum. The 1H NMR spectra for both 
compounds showed sufficient presence of the desired product for conclusive analysis. For both compounds 
56a and 56b, peaks were observed in the upper aromatic region (7.50 and 8.21 ppm) as well as the peaks 
typically observed for 36a and 36b, without the peaks corresponding to the primary alkynyl and the 
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1 56a t-BuOH: 
H2O 
24h RT Cu(SO4)∙5H2O 0.2 75 
2 56a DMSO 24h RT Cu(SO4)∙5H2O 0.2 97 
3 56b t-BuOH: 
H2O 
24h RT Cu(SO4)∙5H2O  0.2 65 
4 56b DMSO 24h RT Cu(SO4)∙5H2O  0.2 78 
 
Although compounds 52a, 54a, 56a and 56b showed previously mentioned yields significant 
enough for further analysis. These compounds were not sufficiently pure for biological testing; however, 
flash column chromatography of 52a provided significant data for further purification using a DCM: 
methanol gradient. It was concluded that further purification with semi-prep HPLC would be required, 
which was unfortunately not achievable due to time constraints. The irreproducibility of those reactions 




Twelve 4-aza-podophylltoxin analogues for Library 1 were successfully synthesized from the 6 N-
functionalized anilines. Although other anilines were synthesized during this project, they did not yield the 
desired 4-aza-podophyllotoxin analogues in yields sufficient for analysis. It was found that most products 
in Library 1 were synthesized in yields below 50%. It was, however, clear that those reactions that made 
use of microwave irradiation and 4-chloroaniline provided more significant yields. It was also proven that 
the products from Library 1 can undergo further functionalization without affecting the central 4-aza-
podoophylltoxin scaffold. The 4N-functionlaised 4-aza-podophylltoxin derivatives from Library 1 were all 
synthesized in yields sufficient for further analysis. Of these 12 compounds, six contained the phenolic 
group in the R2 position and six the methoxy moiety, making them ideal for comparative analysis.  
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Four compounds were generated for Library 2. These compounds were successfully synthesized 
but require further purification before biological testing. Of these, three contain the phenolic moiety in the 
R2 position and one contains the methoxy moiety in the R2 position. One analogue was successfully coupled 
to a fluorescent marker, making it ideal for further biological testing. It was observed that those click 
reactions which employed THPTA as a ligand performed significantly better than those that did not.  
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 Chapter 3: Experimental methods 
The main method of synthesis applied in this research was the multicomponent reaction developed 
by Giorgi Renault et al. in 2010 (as discussed in the literature review).70 This process, which has been 
optimized and altered by various groups, remains a key method of synthesis.1 The current most accepted 
mechanistic route is discussed by Jeedimalla et al. This group also inspired the use of sacrificial aniline, 
para-chloroaniline, in this project.43  
This chapter will begin by presenting the syntheses undertaken. The synthesis of Library 1 is then 
described, starting with the synthesis of N-functionalized anilines, followed by the synthesis of 4N-
functionlized-aza-podophyllotoxins, and finally the synthesis of modified compounds from Library 1. 
Library 2 is then discussed. Library 2 was synthesized from products 36a/b from Library 1, and a set of 
azide compounds. The section discussing Library 2 begins with the synthesis of the azides and ends with 
the 4-aza-podophyllotoxin click reaction products.  
3.1 General information regarding experimental procedures  
 Chemicals and solvents 
The chemicals used in this study were purchased from Sigma Aldrich and Merck, or were sourced 
from the De Beers Building chemical stores. Ethyl acetate, DCM and hexane were distilled open to the 
atmosphere before use and were used for TLC plate separation and column chromatography. The solvents 
used for reactions were distilled under inert conditions over a suitable drying agent: CH2Cl2 and acetonitrile 
over calcium hydride, toluene and tetrahydrofuran (THF) over sodium (benzophenone as indicator for the 
THF still). These solvents were also stored over 4 Å molecular sieves when distilled. 
 Laboratory equipment and consumables 
Reactions were heated in oil baths using either silicon oil or paraffin oil, unless otherwise specified, 
using magnetic heater stirrers equipped with temperature probes. Solvents were removed under reduced 
pressure using Büchi RII Rotovapor rotary evaporators with Büchi V-700 Vacuum Pumps, equipped with 
V-850 Vacuum controllers, and the final trace amounts of solvents were removed by means of an Edwards 
high vacuum pump, capable of sustaining a vacuum of 0.08 mmHg. Glassware was dried in an oven at a 
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temperature of 110 °C. Compounds were stored in Bosch refrigerators and freezers, which were kept at 
2 °C and -22 °C respectively. Machery-Nagel ALUGRAM® Xtra SIL G UV254 aluminium sheets were 
used for thin layer chromatography (TLC) analyses and 254 nm and 365 nm UV lights used for visualization. 
Various stains were used for the permanent development of TLC plates, including ninhydrin, potassium 
permanganate, cerium ammonium molybdate, bromocresol green and p-anisaldehyde. Iodine was used as 
a reversible stain.  
Column chromatography was done with Merck silica gel (particle size range of 0.063-0.200 mm 
with 60 Å pores). Auto-column chromatography was performed using a combiFlash®Rf 150, made by 
TYLEDYNE ISCO. The microwave apparatus used was a CEM Focused MicrowaveTM Synthesis System, 
Discover ®SP.  
Melting points were obtained using a Gallenkamp Melting Point Apparatus. Infrared spectra were 
obtained using a Nexus Thermo-Nicolet FT-IR instrument using the ATR function. High resolution mass 
spectrometry was performed by the CAF (Central Analytical Facility) at Stellenbosch University using 
either a Waters API Q-TOF Ultima spectrometer or introduced via the ASAP probe using the Waters Synapt 
G2 spectrometer. Routine mass spectroscopy was performed using a Waters API Quattro Micro 
spectrometer. In all cases ESI+ was used as an ionisation method. EPR spectra were recorded at 298 K 
with a Bruker EMXplus X-band EPR spectrometer (8-inch ER 072 magnet, 2.7 kW power supply, EMX-
m40X microwave bridge operating from 9.3 to 9.9 GHz), and a high sensitivity continuous-wave 
resonator.  
Samples were polycrystalline solids and dilute solutions of arbitrary concentration in dry 
dichloromethane or acetone in an otherwise ambient atmosphere. All chromatography was performed 
using either petroleum ether, hexane, ethyl acetate, methanol and dichloromethane (or a combination of 
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3.2 Library 1: 4-aza-podophylltoxin analogues from N-functionalized anilines 
 Synthesis of N-functionalized anilines  
 Synthesis of Ethyl benzo[d][1,3]dioxol-5-ylglycinate (27) 
 
Scheme 12: synthesis of methyl ester functionalized aniline (27) 
3,4-(Methylenedioxy)aniline SM1 (0.10 g, 1.0 eq, 0.73 mmol) was added to a solution of 
chloroethyl acetate (0.08 mL, 1.0 eq, 0.73 mmol), K2CO3 (0.10 g, 1.0 eq, 0.73 mmol) and THF (10 mL). 
The solution was then left to reflux for 96 h at 66 °C while stirring. The reaction mixture turned deep brown 
and was then quenched with saturated NH4Cl (0.30 mL). The deep brown solution was then extracted with 
EtOAc (3 × 15 mL) and the organic layer dried using MgSO4, filtered and concentrated in vacuo. The crude 
material was purified using column chromatography with EtOAc:Hexane gradient starting at 10% as eluent 
to obtain the product 27, a yellow crystalline solid, in a yield of 51% (83 mg). 
This reaction was then scaled up by a factor of five and was successful in producing compound 27, 
in a yield of 48% (0.39 g). 
1H NMR (400 MHz, CDCl3) δ 6.66 (d, J = 8.3 Hz, 1H, Ar), 6.27 (d, J = 2.3 Hz, 1H, Ar), 6.05 (dd, 
J = 8.3, 2.3 Hz, 1H, Ar), 5.86 (s, 2H, -OCH2O-), 4.24 (q, J = 7.1 Hz, 2H, O-CH2CH3), 3.84 (s, 2H, - 
NHCH2-), 1.29 (t, 7.1 Hz, -CH3).13C NMR (100 MHz, CDCL3) δ 171.06, 148.38, 142.53, 140.33, 108.58, 
104.71, 100.67, 96.42, 61.28, 46.85, 14.15. HRMS: calculated mass for C11H14NO4 [M+H] 224.0923; found 
224.0923 m/z. ATS FT-IR cm-1: 781, 807, 843, 902, 929, 1021, 1037, 1194, 1239, 1487, 1729, 2847, 3385. 
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 Synthesis of Ethyl 3-(benzo[d][1,3]dioxol-5-ylamino) propanoate (28)  
 
Scheme 13: Synthesis of ethyl ester functionalized aniline (28) 
3,4-(Methylenedioxy)aniline SM1 (0.50 g, 1.0 eq, 3.7 mmol) and ethyl acrylate (0.40 mL, 1.0 eq, 
3.7 mmol) were added to a 10 mL round bottom flask. This was then placed under conventional heating for 
72 hours at 60 °C while stirring. A TLC plate of the final compound showed the formation of a distinct 
product peak. The resulting mixture was diluted with DCM and wet loaded onto a gravity column, where 
EtOAc: Hexane, started at 10%, was used as eluent. The final compound, 28, a yellow-orange oil was 
obtained in a yield of 56% (0.48 g). 
1H NMR (600 MHz, CDCl3) δ 6.62 (d, J = 8.3 Hz, 1H, Ar), 6.23 (d, J = 2.3 Hz, 1H, Ar), 6.04 (dd, 
J = 8.3, 2.3 Hz, 1H, Ar), 5.82 (s, 2H, -OCH2O-), 4.13 (q, J = 7.1 Hz, 2H, OCH2CH3), 3.34 (t, J = 6.3 Hz, 
2H, NHCH2CH2), 2.56 (t, J = 6.4 Hz, 2H, NHCH2CH2), 1.23 (t, J = 7.2 Hz, 3H, OCH2CH3). 13C NMR (100 
MHz, CDCl3) δ 172.32, 148.35, 143.07, 139.99, 108.58, 105.01, 100.57, 96.46, 60.58, 40.63, 33.75, 14.14. 
HRMS: calculated mass for C12H16NO4 [M+H] 238.1079; found 238.1071 m/z. ATS FT-IR cm-1: Product 
showed signs of degradation, potentially due to storage conditions, making IR inconclusive. Further 
methods used for synthesis are discussed in Chapter 2 in Table 2, page 38.  
 Synthesis of N-(but-3-yn-1-yl) benzo[d][1,3]dioxol-5-amine (29) 
 
Scheme 14: Synthesis of propyne functionalized aniline (29) 
3,4-(Methylenedioxy)aniline SM1 (0.10 g, 1.0 eq, 0.73 mmol) was added to propargyl bromide 
(0.11 mL, 1.0 eq, 0.73 mmol), K2CO3 (0.10 g, 1.0 eq, 0.73 mmol) and DMF (5.0 mL). The solution was 
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then left to reflux for 2 hours at 90 °C while stirring. The reaction mixture turned deep brown and was then 
quenched with saturated NH4Cl (0.5 mL) and water (5.0 mL) and concentrated in vacuo. The deep brown 
solution was then extracted with EtOAc (3 × 15 mL) and the organic layer dried using MgSO4, filtered and 
concentrated in vacuo. The crude material was purified using column chromatography with EtOAc:Hexane 
gradient starting at 10% as eluent to obtain the product 29, a yellow oil, in a yield of 72% (92 mg). This 
reaction was repeated and scaled up by a factor of five with similar results (71% yield, 0.91 g). 
1H NMR (400 MHz, CDCl3) δ 6.69 (d, J = 8.3 Hz, 1H, Ar), 6.32 (d, J = 2.3 Hz, 1H, Ar), 6.13 (dd, 
J = 8.3, 2.3 Hz, 1H, Ar), 5.87 (s, 2H, -OCH2O-), 3.87 (d, J = 2.4 Hz, 2H,-NHCH2C-), 3.62 (s, 1H, -NH-), 
2.22 (s, 1H, -CCH).13C NMR (100 MHz, CDCl3) δ 148.35, 142.42, 140.57, 108.56, 105.45, 100.73, 96.86, 
81.09, 71.38, 34.59. HRMS: calculated mass for C10H10NO2 [M+H] 176.0712, found- 176.0706 m/z. ATS 
FT-IR cm-1: 660, 708, 749, 970, 812, 836, 896, 917, 1031, 1068, 1111, 1119, 1149, 1199, 1229, 1258, 
1314, 1371, 1438, 1455, 1482, 1502, 1632, 25891, 3253, 3390.MP: 76-78 °C. 
 Synthesis of N-(4-nitrobenzyl) benzo[d][1,3]dioxol-5-amine (30) 
 
Scheme 15: synthesis of para-nitrobenzene functionalized aniline (30) 
4-Nitrobenzaldehyde (0.15 g, 1.0 eq, 1.0 mmol) and ZnBr2 (0.25 g, 1,1 eq, 1.1 mmol) were added 
to acetonitrile and stirred for 20 minutes at room temperature. 3,4-(Methylenedioxyaniline) SM1 (0.14 g, 
1.0 eq, 1.0 mmol) was then added to the reaction mixture. This was stirred for 24 hours at room temperature. 
Sodium borohydride (76 mg, 2.0 eq, 2.0 mmol) was then added to the reaction mixture. The reaction was 
then left to stir at room temperature for 12 hours. The reaction was quenched with saturated NH4Cl (0.50 
mL) and water (5.0 mL) and concentrated in vacuo. The deep brown solution was extracted with EtOAc (3 
× 15 mL) and the organic layer dried using MgSO4, filtered and concentrated in vacuo. The crude material 
was purified using column chromatography with EtOAc:Hexane gradient starting at 10% as eluent to obtain 
the product 30, a red crystalline material, in a yield of 60% (0.16 g). 
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 70 
1H NMR (300 MHz, CDCl3) δ 8.28 – 8.05 (dd, J = 1.9 Hz, 2H, Ar-NO2), 7.60 – 7.42 (dd, J = 8.3, 
0.6,  2H, Ar-NO2), 6.62 (d, J = 8.3 Hz, 1H, Ar), 6.21 (d, J = 2.4 Hz, 1H, Ar), 5.99 (dd, J = 8.3, 2.4 Hz, 1H, 
Ar), 5.83 (d, J = 0.5 Hz, 2H, -OCH2O-), 4.40 (s, 2H, -NHCH2). 13C NMR (75 MHz, CDCl3) δ 148.52, 
147.63, 147.21, 143.10, 140.17, 127.82, 123.93, 108.75, 104.55, 100.79, 96.13, 48.51. HRMS: calculated 
mass for C12H15NO4 [M+H] 273.0875, found- 273.0868 m/z. ATS FT-IR cm-1:741, 787, 826, 840, 1106, 
1148, 1202,1234, 1291, 1342, 1396, 1428, 1463, 1502, 1515, 1605, 1630, 2846, 2903, 3076, 3388. MP: 58-
60 °C. 
 Synthesis of N-(3-nitrobenzyl)benzo[d][1,3]dioxol-5-amine (31) 
 
Scheme 16: Synthesis of meta-nitro benzene functionalized aniline (31) 
3-Nitrobenzaldehyde (0.15 g, 1.0 eq, 1.0 mmol) and ZnBr2 (0.25 g, 1,1 eq, 1.1 mmol) were added 
to acetonitrile and stirred for 20 minutes at room temperature. 3,4-(Methylenedioxy)aniline SM1 (0.14 g, 
1.0 eq, 1.0 mmol) was then added to the reaction mixture. This was stirred for 24 hours at room temperature. 
Sodium borohydride (76 mg, 2.0 eq, 2.0 mmol) was then added to the reaction mixture. The reaction was 
left to stir at room temperature for 12 hours. The reaction was quenched with saturated NH4Cl (0.50 mL) 
and water (5.0 mL) and concentrated in vacuo. The deep brown solution was extracted with EtOAc (3 × 15 
mL) and the organic layer dried using MgSO4, filtered and concentrated in vacuo. The crude material was 
purified using column chromatography with EtOAc:Hexane gradient starting at 10% as eluent to obtain the 
product 31, a red crystalline material, in a yield of 70% (0.19 g). 
1H NMR (300 MHz, CDCl3) δ 8.21 (dd, J = 2.0 Hz, 1H, ArNO2), 8.09 (dd, J = 8.2, 2.4 Hz, 1H, 
ArNO2), 7.69 (d, J = 7.6 Hz, 1H, ArNO2), 7.49 (dd, J = 8.7, 7.1 Hz, 1H, ArNO2), 6.63 (dd, J = 8.3, 1.6 Hz, 
1H, Ar), 6.22 (dd, J = 2.0 Hz, 1H, Ar), 6.01 (dd, J = 8.3, 2.0 Hz, 1H, Ar), 5.83 (s, 2H, -OCH2O-), 4.38 (s, 
2H, -NHCH2), 4.05 (s, 1H, -NH). HRMS: calculated mass for C14H13N2O4 [M+H] 273.0875, found- 
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278.0871 m/z. ATS FT-IR cm-1:787, 840, 1033, 1193, 1343,1484, 1500, 1515, 1604, 1629, 2846, 2904, 
3387. MP: 52-56 °C. 
 Synthesis of N-(3-(benzo[d][1,3]dioxol-5-ylamino)propyl)-4-methylbenzenesulfonamide (32) 
 
Scheme 17: Synthesis of tosyl protected propyl amine functionalized aniline (32) 
Tosyl chloride (1.0 g, 2.0 eq, 5.3 mmol) and 1-aminopropanol (0.20 g, 0.20 mL, 1.0 eq, 2.6 mmol) 
were added to DCM (10 mL) and stirred for four hours at room temperature. The reaction was then 
quenched by dissolution. The product was then loaded onto silica gel and purified using column 
chromatography using an EtOAc:Hexane gradient starting at 20% EtOAc was used as eluent to obtain the 
product, a white crystalline solid, in a yield of 22% (0.22 g). HRMS: calculated mass for C17H22NO5S2 
[M+H] 384.0939; found 384.0932 m/z and confirmed by comparison to literature.54 
This product, 3-(4-methylphenylsulfonamido)propyl 4-methylbenzenesulfonate (0.22 g. 1 eq, 0.6 
mmol) was then added to 3,4-(methylenedioxy)aniline SM1 (78 mg, 1.0 eq, 0.6 mmol) and K2CO3 (9.2 g, 
1.2 eq, 0.7 mmol) in THF and stirred for 12 hours at 60 °C. The reaction mixture turned deep brown and 
was then quenched with saturated NH4Cl (0.30 mL). The solution was extracted with EtOAc (3 × 15 mL) 
and the organic layer dried using MgSO4, filtered and concentrated in vacuo. The crude material was 
purified using column chromatography with EtOAc:Hexane gradient starting at 10% used as eluent to 
obtain the product 32, which co-eluted with starting material, in a total yield of 8% (16 mg) this reaction 
was repeated and was a yield of 50 mg crude product, which was used in the subsequent reaction. 
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1H NMR (300 MHz, CDCl3) δ 6.61 (d, J = 8.2 Hz, 3H), 6.28 (d, J = 2.3 Hz, 3H), 6.12 (dd, J = 8.2, 
2.3 Hz, 3H), 5.85 (s, 6H), 4.12 (q, J = 7.1 Hz, 1H), 3.28 – 3.16 (m, 1H), 3.24 (s, 2H), 2.44 (d, J = 9.3 Hz, 
1H), 1.26 (t, J = 14.3 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 148.73, 141.93, 140.89, 130.29, 127.58, 
109.10, 107.41, 101.19, 98.61, 78.01, 77.58, 77.16, 60.94, 47.51, 21.58, 14.74, 1.56. ATS FT-IR cm-1: 662, 
706, 776, 811, 858, 900, 929, 1020, 1050, 1063, 1094, 1162, 1290, 1302, 1322, 1381, 1444, 1462, 1477, 
2867, 2949, 2126, 3498. Mass spectral data was not obtained due to degradation of the product at the time 
of analysis, as a result, the product remains unidentified. 
 
 4-aza-podophyllotoxin analogues 
Scheme 18 shows the generalized scheme used for the synthesis of the 4-aza-podophyllotoxins in 







Scheme 18: Generalized method for the synthesis of 4-aza-podophylltoxin analogues; generalized 
multicomponent reaction  
The synthesis of the 4-aza-podophyllotoxins are represented in Tables 7 and 8. All synthesis 
followed the general procedure described below, unless stated otherwise.  
The 4-aza-podophyllotoxin analogues below were synthesized in Library 1 from their respective 
anilines, 29-32. These reactions were performed under air atmosphere, unless otherwise specified. 
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 73 
 
Figure 20: 4-aza-podophyllotoxin analogues synthesized (33-38) 
Synthetic procedure for compounds A 
The functionalized aniline (27-32) (1.0 eq, 1.0 mmol), syringaldehyde (0.18 g, 1.0 eq, 1.0 mmol), 
tetronic acid (0.11 g, 1.0 eq, 1.0 mmol), 4-chloroaniline (13 mg, 0.1 eq, 0.1 mmol) and ethyleneglycol (1.5 
mL) were added to a 10 mL microwave reaction vessel. The solution was heated to 196 °C for 30 seconds 
while stirring to dissolve reactants. Following this, the reaction vessel was placed under microwave 
irradiation and heated to the temperatures and time periods designated in Table 7. The products (33a-39a), 
were recovered via filtration and washed with 3 × 5 mL cold ethanol. The precipitate was then recrystallized 
in ethanol and recovered by filtration and washed again with cold ethanol (3 × 5 mL). Compound 
characterization for individual products follows below.  
Table 8: Methods used for the synthesis of compounds 33a-38a 
Product Time in minutes Temperature 
in °C 
Heating method Yield in % 
33a 120 180 MWI 44 
34a 120 180 MWI 8 
35a 120 75 MWI 36 
36a 7.5 110 MWI 32 
37a 0.5 198 Conventional 61 
38a 10 150 MWI 43 
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 Analysis of ethyl 2-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-6,9-dihydro-[1,3]dioxolo[4,5-g] 
furo[3,4-b] quinolin-5(8H)-yl]acetate (33a) 
 
Figure 21: Structure of methyl ester functionalised compound 33a 
The best yield obtained was 44% (0.21 g). 
1H NMR (300 MHz, DMSO-d6) δ 8.13 (s, 1H, -OH, E ring), 6.82 – 6.70 (m, 2H, Ar, B-Ring), 6.53 
(s, 2H, -OCH2O-), 5.95 (dd, J = 16.2, 1.0 Hz, 2H, Ar, E ring), 5.06 (d, J = 16.0 Hz, 1H, -CCH2O-), 4.90 
(dd, J = 16.0, 1.1 Hz, 1H, -CCH2O), 4.78 (s, 1H, CCHC, C ring), 4.72 (d, J=18.6 Hz, 1H, NCH2C), 4.56 
(d, J = 18.6 Hz, 1H, NCH2C), 4.18 (q, J = 7.1 Hz, 2H, -CH2CH3), 3.70 (s, 6H, 2×-OCH3, E ring), 1.23 (t, J 
= 7.1 Hz, 3H, CH2CH3). 13C NMR (75 MHz, DMSO-d6) δ 173.3, 168.6, 159.49, 147.9, 146.8, 143.4, 137.2, 
134.3, 131.4, 119.4, 109.9, 105.1, 102.3, 96.9, 95.5, 65.23, 61.3, 56.0, 47.5, 14.0. ATS FT-IR cm-1: 932, 
986, 1016, 1054, 1115, 1205, 1235, 1434, 1452, 1462, 1471, 1514, 1615, 1660, 1744, 1731, 3511. HRMS: 
calculated mass for C24H24NO9 [M+H] 470.1451; found 470.1446 m/z. MP 235-237 °C. 
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 Analysis of ethyl 3-(9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-[1,3]dioxolo[4,5-g]furo[3,4-
b]quinolin-5(6H,8H,9H)-yl)propanoate (34a) 
 
Figure 22: Structure of ethyl ester functionalized compound 34a 
The best yield obtained was 8% (39 mg). This reaction was repeated with similar results. 
1H NMR (300 MHz, DMSO-d6) δ 8.77 (s, 1H, OH, E ring), 7.52 (s, 1H, Ar, B ring), 7.13 (s, 1H, 
Ar, B ring), 6.69 (s, 2H, Ar, E ring), 6.75 – 6.54 (m, 1H, Ar, E ring), 6.29 (s, 2H, Ar, A ring), 5.41 (s, 2H-
CCH2O-), 3.75 (s, 3H, 2 × OCH3, E ring), 3.88 – 3.64 (m, 3H, CH2CH3), 3.43 (s, 2H, CH2CH2), 1.28 – 1.13 
(t, 2H, -CH2CH3). 13C NMR (75 MHz, DMSO-d6) δ 168.44, 163.48, 153.45, 150.48, 149.01, 148.93, 148.15, 
136.82, 124.08, 122.33, 112.43, 108.03, 105.41, 103.49, 102.37, 69.27, 63.25, 56.63. ATS FT-IR cm-1: 858, 
1033, 1113,1190, 1267,1332, 1368, 1421, 1451, 1503, 1555, 1608, 1655, 1722, 2940, 3496. HRMS: 
calculated mass for C25H25NO9 [M+H] 484.16; found 484.1596 m/z. ATS FT-IR cm-1: 858, 1033, 1113,1190, 
1267,1332, 1368, 1421, 1451, 1503, 1555, 1608, 1655, 1722, 2940, 3496. MP 240-242 °C. 
 Analysis for unknown compound initially thought to be 35a 
An unknown mixture of two products was obtained when the synthesis of 35a was attempted. The 
individual products could not be separated, despite further attempts at recrystallization. The unknown minor 
product appeared in the 1H NMR spectra in very small amounts, making integration inaccurate for these 
peaks. The peaks have been designated ‘m’ for the minor product and ‘M’ for the major product in the 1H 
NMR spectrum. Initial synthesis of compound 35a, was not successful, this is discussed in further detail in 
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Chapter 2. Optimization for the synthesis for N-functionalized aniline 32 will need to be performed before 
further attempts at synthesis can be undertaken. The analytical data for this mixture is presented below.  
1H NMR (400 MHz, DMSO-d6) δ 9.77 (s, m), 8.19 (s, 2H, M), 7.84 (s, 1H,), 7.21 (s, m), 6.54 (s, 
m), 4.67 (s, 1H, M), 3.86 (s, 2H, M), 3.39 (s, m), 2.08 (s, m), 1.31 – 1.02 (m, m). Potentially corresponding 
to major peak at 398.2332 m/z in the mass spectrum. 13C NMR (101 MHz, DMSO-d6) δ 196.31, 195.00, 
190.93, 180.42, 176.70, 170.68, 168.47, 154.11, 151.90, 147.90, 147.43, 144.63, 141.87, 135.68, 133.42, 
126.93, 123.78, 122.48, 113.83, 113.03, 106.86, 104.44, 98.05, 72.32, 71.30, 67.41, 62.58, 57.01, 56.01, 
55.95, 55.86, 55.81, 54.82, 32.20, 30.50. HRMS: calcd for C30H30N2O9S mass [M+H] 595.1750 m/z found 
minor peak at 595.0836 m/z, and major peaks at 546.0695, and 398.2332 m/z. ATS FT-IR cm-1:686, 705, 
877, 983, 1020,1053,1108, 1138, 1161, 1228, 1275, 1324, 1367, 1442, 1493, 1558, 1667, 1745, 3229. MP: 
186-192 °C.  
 Analysis of 9-(4-hydroxy-3,5-dimethoxyphenyl)-5-(prop-2-yn-1-yl)-6,9-dihydro-[1,3]dioxolo [4,5-
g]furo[3,4-b]quinolin-8(5H)-one (36a) 
 
Figure 23: Structure of propargyl functionalized compound 36a 
The best yield obtained was 32% (0.14 g). This reaction was repeated and scaled up by a factor of 
3 with similar results obtaining a yield of 32% (0.38 g), for use in click reactions.  
1H NMR (400 MHz, DMSO-d6) δ 8.16 (s, 1H, -OH, E ring), 6.98 (s, 1H, Ar, A ring), 6.77 (s, 1H, 
Ar A ring), 6.42 (d, J = 1.7 Hz, 2H, -OCH2O-), 6.00 (s, 1H, Ar, E ring), 5.95 (s, 1H, Ar, E ring), 5.19 (d, J 
= 16.1 Hz, 1H, -CCH2O-), 4.96 (d, J = 16.0 Hz, 1H, -CCH2O-), 4.78 (s, 1H, -CCHC-, C ring), 4.61 (dd, J 
= 6.3, 2.5 Hz, 2H, -NCH2C), 3.67 (s, J = 1.6 Hz, 6H, 2×-OCH3, E ring), 3.40 (d, J = 2.2 Hz, 1H, -CCH). 
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13C NMR (75 MHz, DMSO-d6) δ 216.46, 172.29, 159.36, 148.36, 147.18, 144.00, 137.39, 134.79, 131.05, 
120.22, 110.29, 105.26, 101.91, 97.92, 96.97, 78.76, 76.14, 65.58, 63.26, 56.47, 36.09. HRMS: calculated 
mass for C23H20NO7 [M+H] 422.1240; found 422.1238 m/z. ATS FT-IR cm-1:686, 707, 768, 794, 832, 873, 
937, 978, 1015, 1044, 1111, 1204, 1238, 1318, 1427, 1454, 1478, 1608, 1643, 1726, 2898, 3245, 3554. MP 
210-212 °C. 
 Analysis of 9-(4-hydroxy-3,5-dimethoxyphenyl)-5-(4-nitrobenzyl)-6,9-dihydro [1,3]dioxolo [4,5-
g]furo[3,4-b]quinolin-8(5H)-one (37a) 
 
Figure 24: Structure of nitrobenzene functionalized compound 37a 
The best yield obtained was 61% (0.32 g). This was achieved under conventional heating for 30 
seconds.  
1H NMR (300 MHz, DMSO-d6) δ 8.27 – 8.14 (m, 2H, Ar-NO2), 7.67 – 7.54 (m, 2H, Ar-NO2), 6.76 
(d, J = 0.6 Hz, 1H, Ar, B ring), 6.67 (s, 1H, Ar, B ring), 6.47 (s, 2H, -OCH2O-), 5.90 (s, 2H, 2 × Ar, E ring), 
5.26 – 4.85 (m, 5H,  -CCHC-,-CCH2O-, -NCH2C-), 3.71 (s, 6H, -OCH3). 13C NMR (75 MHz, DMSO-d6) 
206.22, 171.76, 159.21, 147.65, 146.67, 146.41, 144.36, 143.21, 136.75, 134.08, 130.56, 127.42, 123.62, 
119.23, 109.82, 104.78, 101.14, 96.08, 96.04, 65.14, 62.51, 55.71, 48.20, 40.08, 39.80, 39.68, 39.52, 39.24, 
38.96, 38.68, 38.41, 30.41. HRMS: calculated mass for C27H23N2O9 [M+H] 519.1404; found 519.1406 m/z. 
ATS FT-IR cm-1: 728, 765, 872, 929, 980, 994, 1032, 1111, 1196, 1229, 1320, 1342, 1459, 1476, 1515, 
1612, 1655, 1729, 2876, 2935, 3341, 3482. MP 196-200 °C. 
 
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 78 
 Analysis of 9-(4-hydroxy-3,5-dimethoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-
b]quinolin-8(5H)-one (38a) 
 
Figure 25:  Unfunctionalized compound 38a and oxidized form of the compound 
The best yield obtained was 43% (0.16 g). 
NMR reported for the mixture of both forms of 38a: 1H NMR (300 MHz, DMSO-d6) δ 9.83 – 9.77 
(s, 2H), 8.82 – 8.76 (s, 1H), 8.19 – 8.13 (s, 2H), 7.54 – 7.46 (s, 1H), 7.17 – 7.11 (s, 1H), 6.74 – 6.68 (s, 1H), 
6.67 – 6.61 (s, 2H), 6.55 – 6.41 (d, J = 21.8 Hz, 6H), 6.31 – 6.25 (s, 1H), 5.99 – 5.87 (dd, J = 14.1, 1.0 Hz, 
4H), 5.43 – 5.37 (s, 1H), 5.03 – 4.92 (d, J = 15.6 Hz, 2H), 4.89 – 4.78 (d, J = 15.7 Hz, 2H), 4.82 – 4.74 (s, 
2H), 3.79 – 3.73 (s, 3H), 3.73 – 3.66 (s, 12H), 3.43 – 3.37 (s, 1H).13C NMR (75 MHz, DMSO-d6) δ 172.63, 
163.45, 158.68, 153.42, 148.34, 148.15, 146.79, 143.62, 137.89, 136.83, 134.75, 130.70, 122.34, 117.50, 
112.39, 110.02, 108.04, 105.65, 101.58, 97.68, 94.84, 65.33, 56.63, 56.50. HRMS: calculated mass for 
C20H16NO7 [M+H] 382.0927; found 382.0922 m/z. ATS FT-IR cm-1:684, 758, 778, 790, 807, 818, 851, 866, 
933, 1015, 1032, 1066, 1103, 1115, 1165, 1192, 1246, 1303, 1329, 1348, 1425, 1460, 1481, 1498, 1551, 
1621, 1656, 1731, 3334. MP 234-236 °C. 13C spectrum of unoxidized product was not obtained. 
Synthetic procedure for compounds B 
The functionalized aniline (27-32) (1.0 eq, 1.0 mmol), trimethoxy benzaldehyde (0.20 g, 1.0 eq, 
1.0 mmol), tetronic acid (0.11 g, 1.0 eq, 1.0 mmol), 4-chloroaniline (13 mg, 0.10 eq, 0.10 mmol) and 
ethyleneglycol (1.5 mL) were added to a 10 mL microwave reaction vessel. The solution was then heated 
to 196 °C for 30 seconds while stirring to dissolve reactants. Following this the reaction vessel was placed 
under microwave irradiation and heated to the temperature, and time period designated in Table 8. The 
product (33b-39b), was recovered via filtration and washed with 3 × 5 mL cold ethanol. The precipitate 
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was then recrystallized in ethanol and recovered by filtration and washed with cold ethanol (3 × 5 mL). 
Compound characterization for individual products follows below. 
Table 9: Methods used for the synthesis of 33b-38b 
Product Time in minutes Temperature 
in °C 
Heating method Yield in % 
33b 120 180 MWI 35 
34b 120 180 MWI 14 
35b 35 75 MWI 87 
36b 10 150 MWI 66 
37b 0.5 198 Conventional 15 
38b 10 150 MWI 28 
 
 Analysis of Ethyl 2-[8-oxo-9-(3,4,5-trimethoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5g]furo[3,4-
b]quinolin-5(8H)-yl]acetate (33b) 
 
Figure 26: Structure of methyl ester functionalized compound 33b 
The best yield obtained was 35% (0.17 g). 
1H NMR (400 MHz, DMSO-d6) δ 6.79 (s, 1H, Ar, B ring), 6.75 (d, J = 0.6 Hz, 1H, Ar, B ring), 
6.59 (s, 2H, -OCH2O-), 5.98 (d, J = 1.0 Hz, 1H, Ar, E ring), 5.93 (d, J = 1.1 Hz, 1H, Ar, E ring), 5.14 – 
4.55 (m, 5H, CCHC-,-CCH2O-, -NCH2C-),4.18 (q, J = 7.1 Hz, 2H, OCH2CH3), 3.72 (s, 6H, 2 ×-OCH3, E 
ring), 3.59 (s, 3H, -OCH3), 1.22 (t, J = 7.1 Hz, 3H,-CH2CH3). 13C NMR (100 MHz, DMSO-d6) δ 167.64, 
162.69, 152.89, 152.42, 149.82, 147.56, 137.56, 127.43, 123.22, 111.79, 106.97, 104.73, 102.88, 101.52, 
68.71, 62.57, 59.91, 55.84, 55.53, 39.99, 39.94, 39.78, 39.73, 39.57, 39.52, 39.31, 39.10, 38.90, 38.69.ATS 
FT-IR cm-1: 932, 986, 1016, 1054, 1115, 1205, 1235, 1434, 1452, 1462, 1471, 1514, 1615, 1660, 1744, 
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1731, 3511. HRMS: calculated mass for C25H26NO9 [M+H] 484.1608; found 484.1602 m/z. MP: 224-
228 °C. 
 Analysis of ethyl 3-(8-oxo-9-(3,4,5-trimethoxyphenyl)-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-
5(6H,8H,9H)-yl)propanoate (34b) 
 
Figure 27: Structure of ethyl ester functionalized compound 34b 
The best yield obtained was 14% (69 mg) 
1H NMR (400 MHz, DMSO-d6) δ 7.55 (s, 1H, Ar, B ring), 7.08 (s, 1H, Ar, B ring), 6.74 (s, 2H, -
OCH2O-), 6.30 (s, 2H, Ar, E ring), 5.44 (s, 2H, -CCH2O-), 3.87 – 3.57 (m, 16H, 3 × -OCH3, NCH2CH2, 
OCH2CH2, OCH2CH3), 3.39 (s, 3H, -OCH3), 1.21 (m, 2H, NCH2CH2).13C NMR (100 MHz, DMSO-d6) δ 
168.30, 163.35, 153.56, 153.09, 150.48, 148.22, 138.22, 128.09, 123.88, 112.45, 107.63, 105.39, 103.54, 
102.18, 69.37, 63.23, 60.57, 56.51, 56.19. HRMS: calculated mass for C26H26NO9 [M+H] 496.1608 found 
496.1609 m/z. ATS FT-IR cm-1: 857, 932, 1004, 1120, 1151, 1187, 1241, 1254, 1297, 1322, 1365, 1414, 
1457, 1498, 1557, 1598, 1611, 1726, 2839, 2931, 3001, 3380, 3417, 3497. MP 236-239 °C. 
 Analysis of unknown compound (35b)  
Initial synthesis of compound 35b, was not successful, this is discussed in further detail in Chapter 
2. Optimization for the synthesis for N-functionalized aniline 32 will need to be performed before further 
attempts at synthesis can be undertaken. The analytical data for this mixture is presented below.  
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1H NMR (300 MHz, DMSO-d6) δ 6.48 (d, J = 3.3 Hz, 2H), 6.34 (s, 1H), 6.18 (s, 1H), 5.87 (dd, J 
= 5.0, 1.0 Hz, 3H), 5.30 (s, 1H), 4.66 – 4.48 (m, 2H), 3.92 – 3.72 (m, 3H), 3.69 (s, 1H), 3.70 – 3.55 (m, 
6H), 3.05 (s, 1H). 13C NMR (75 MHz, DMSO-d6) δ 172.26, 159.57, 153.28, 153.12, 147.33, 146.76, 144.08, 
142.73, 140.60, 139.17, 138.09, 136.57, 136.54, 131.09, 120.83, 119.74, 110.27, 109.37, 107.19, 104.92, 
101.98, 100.79, 97.68, 97.08, 95.70, 82.66, 78.73, 76.17, 73.81, 65.67, 63.25, 60.45, 60.33, 56.27, 44.97, 
36.13, 33.86. HRMS: calculated mass for C32H33N2O9S [M+H] 608.1906 major peaks observed at 595.2324, 
551.1171 and 455.0823 m/z. ATS FT-IR cm-1: 688, 705, 786, 794, 830, 940, 977, 1002, 1014, 1047, 1126, 
1129, 1203, 1229, 1314, 1419, 1449, 1478, 1505, 1588, 1611, 1644, 1729, 2893, 3224, 3254. MP 188-
192 °C. 
 Analysis of 5-(prop-2-yn-1-yl)-9-(3,4,5-trimethoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-
b]quinolin-8(5H)-one (36b) 
 
Figure 28: Structure of propargyl functionalized compound 36b 
The best yield obtained was 66% (0.29 g). This reaction was repeated and scaled up by a factor of 
1.5 resulting in 50% yield (0.33g). 
1H NMR (400 MHz, DMSO-d6) δ 7.00 (s, 1H, Ar, B ring), 6.79 (s, 1H, Ar, B ring), 6.47 (s, 2H, -
OCH2O-), 6.02 (d, J = 1.0 Hz, 1H, Ar, E ring), 5.96 (d, J = 1.1 Hz, 1H, Ar E ring), 5.20 (d, J = 16.0 Hz, 
1H,-CCH2O), 4.97 (d, J = 16.0 Hz, 1H, -CCH2O), 4.84 (s, 1H, CCHC, C ring), 4.70 – 4.53 (m, 2H, -NCH2), 
3.69 (s, 6H, 2 × -OCH3, E ring), 3.59 (s, 3H, -OCH3), 3.44 – 3.39 (m, 1H, -CCH). 13C NMR (100 MHz, 
DMSO-d6) δ 172.26, 159.33, 148.34, 147.15, 143.98, 137.36, 134.77, 131.02, 120.20, 110.27, 105.25, 
101.89, 97.91, 96.95, 78.74, 76.12, 65.56, 63.24, 56.56, 56.44, 56.33, 36.07. HRMS: calculated mass for 
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C24H22NO7 [M+H] 436.1396; found 436.1382 m/z. ATS FT-IR cm-1: 688, 831, 940, 977, 997, 1013, 1047, 
1125, 1203, 1229, 1315, 1420, 1436, 1454, 1477, 1589, 1610, 1643, 1728, 2836, 2892, 2944, 2970, 3224. 




Figure 29: Structure of nitrobenzene functionalized compound 37b 
The best yield obtained was 15% (80 mg), achieved under conventional heating to 198 °C for 30 
seconds.  
1H NMR (400 MHz, DMSO-d6) δ 8.27 – 8.14 (m, 2H, Ar-NO2), 7.65 – 7.55 (m, 2H, Ar-NO2), 6.78 
(d, J = 0.6 Hz, 1H, Ar, A ring), 6.68 (s, 1H, Ar, A ring), 6.52 (s, 2H, -OCH2O-), 5.98 – 5.85 (m, 1H, Ar, E 
ring), 5.80 (s, 1H, -CCHC-), 5.19 (m, 2H, CCH2O), 5.09 – 4.93 (m, 2H, -NCH2C-), 3.73 (s, 6H, 2×OCH3), 
3.61 (s, 3H, -OCH3).13C NMR spectrum is not included as the majority of the product was sent for biological 
testing at YSU. Insufficient yield remained for accurate analysis. When running the sample for 24 hours, 
most peaks had not cleared the baseline. Recovery of the product from YSU was not possible to enable 
further analysis. HRMS: calculated mass for C28H25N2O9 [M+H] 533.1560; found 533.1594 m/z. ATS FT-
IR cm-1: 728, 765, 872, 929, 980, 994, 1032, 1111, 1196, 1229, 1320, 1342, 1459, 1476, 1515, 1612, 1655, 
1729, 2876, 2935, 3341, 3482. MP: 194-198 °C. 
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 Analysis of 9-(3,4,5-trimethoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-
one (38b) 
 
Figure 30: Structure of unfunctionalized compound 38b 
The best yield obtained was 28% (0.11 g). 
1H NMR (300 MHz, DMSO-d6) δ 6.67 (d, J = 2.2 Hz, 1H, Ar, B ring), 6.53 (d, J = 2.2 Hz, 1H, Ar, 
B ring), 6.48 (d, J = 2.2 Hz, 2H, Ar, E ring), 5.93 (dd, J = 15.7, 2.2 Hz, 2H, -OCH2O-), 4.98 (dd, J = 15.7, 
2.2 Hz, 1H, -CCHC-), 4.90 – 4.78 (m, 2H, -CCH2O-), 3.80 – 3.62 (m, 6H, 2 × -OCH3), 3.60 (d, J = 2.2 Hz, 
3H, -OCH3).13C NMR (100 MHz, DMSO-d6) δ 172.16, 158.46, 152.83, 146.52, 143.28, 142.77, 130.37, 
116.57, 109.58, 104.89, 101.21, 97.35, 94.19, 64.98, 59.91, 55.88. HRMS: calculated mass for C21H20NO7 
[M+H] 398.1240; found 398.1236 m/z. ATS FT-IR cm-1: 684, 760, 837, 930, 1007, 1030, 1122, 1159, 1186, 
1201,1235, 1325, 1418, 1461, 1478, 1501, 1555, 1591, 1612, 1644, 1721, 2939, 3080, 3222. MP: 210-
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Scheme 19: Scheme to show the generalized synthesis of 39a and 36b 
The synthesis of compounds 39a and 39b was attempted by reacting LiOH (0.012 g, 1.00 eq, 0.050 
mmol), water (1.00 mL), compound 33a/33b (1.00 eq, 0.05 mmol) and ethanol at room temperature for 12 
hours. The reaction was then quenched using 1 M HCl (1.00 mL), and the organic layer extracted using 3 
× 5 mL EtOAc. The product was concentrated in vacuo. Both 39a and 39b appeared to be orange solids. A 
sample was then run on a TLC plate and stained using Bromocresol green. Both products displayed clear 
yellow spots indicating the presence of 39b and 39b, which were obtained with yields of 99% (39a) and 
43% (39b), respectively. The final product was obtained as a mixture. Analysis of the mixtures is presented 
below. 
 Compound 2-(9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-
5(6H,8H,9H)-yl)acetic acid (39a)  
1H NMR (600 MHz, DMSO-d6) δ 6.77 (s, 2H), 6.73 (s, 1H), 6.54 (s, 3H), 5.97 (d, J = 1.1 Hz, 2H), 
5.92 (d, J = 1.0 Hz, 2H), 5.05 (d, J = 15.9 Hz, 2H), 4.90 (d, J = 16.0 Hz, 2H), 4.77 (s, 2H), 4.64 (s, 1H), 
4.61 (s, 1H), 4.43 (s, 1H), 4.40 (s, 1H), 3.80 – 3.74 (m, 1H), 3.69 (s, 9H), 2.08 (s, 4H), 1.25 (s, 1H), 1.24 
(s, 2H), 0.89 – 0.80 (m, 2H).13C NMR (100 MHz, DMSO-d6) δ 172.42, 170.40, 160.01, 148.26, 147.15, 
143.75, 137.84, 134.57, 131.96, 119.86, 110.35, 105.38, 101.78, 96.94, 95.92, 65.71, 63.22, 56.37, 40.50, 
40.36, 31.11, 22.51. HRMS: calculated mass for C22H20NO9 [M+H] 442.1138; found 442.1134 m/z. ATR 
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FT-IR cm-1: 789, 877, 987, 1032, 1113, 1208, 1360, 1478, 1507, 1612, 1649, 1715, 2922, 3371. MP :166-
169 °C. 
 Compound 2-(8-oxo-9-(3,4,5-trimethoxyphenyl)-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-
5(6H,8H,9H)-yl)acetic acid (39b)  
1H NMR (400 MHz, DMSO-d6) δ 13.27 (s, 1H), 6.80 (d, J = 1.0 Hz, 1H), 6.75 (d, J = 0.7 Hz, 1H), 
6.59 (d, J = 3.1 Hz, 2H), 5.98 (d, J = 1.0 Hz, 1H), 5.93 (d, J = 1.1 Hz, 1H), 5.06 (dd, J = 16.0, 5.0 Hz, 1H), 
4.92 (d, J = 16.0 Hz, 1H), 4.86 – 4.77 (m, 1H), 4.64 (s, 1H), 4.34 (t, J = 5.1 Hz, 1H), 4.18 (q, J = 7.1 Hz, 
1H), 3.71 (d, J = 4.5 Hz, 6H), 3.59 (d, J = 2.3 Hz, 3H), 1.22 (t, J = 7.1 Hz, 1H). The 13C NMR spectrum is 
not presented because after 24 hours of data acquisition, the spectrum showed no peaks above the baseline 
for one of two reasons; either due to their being insufficient material for analysis or that the NMR 
spectroscopic instrument not being sufficiently sensitive. Alternatively, an issue with the data acquisition 
occurred – this spectrum will be re-run when material is resynthesized. This HRMS: calculated mass for 
C23H22NO9 [M+H] 456.1295; found 456.1276 m/z. ATR FT-IR cm-1: 931, 1031, 1120, 1197, 1239, 1361, 
1418, 1463, 1503, 1584, 1651, 1738, 2853, 2922, 3405. MP:172-178 °C. 
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3.3 Click reactions used in the synthesis of Library 2 
This section focuses on the synthesis of the azide alkyne cycloaddition products synthesized in 
Library 2. It begins with the synthetic procedures used to synthesize the desired azides, and their 
characterization. It then describes the methods used to perform the click reaction using products 36a and 
36b from Library 1 as a starting point. 
 The azides represented in Figure 27 were synthesized for use in the synthesis of Library 2. 
 
Figure 31: Azides synthesized for use in azide alkyl cycloaddition (40-45)  
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 Synthesis of azides 40-45 
 Synthesis of N-(2-azidoethyl) naphthalene-1-sulfonamide (40) 
 
Scheme 20: Synthesis of product 40 from dansyl chloride 46 
Ethanolamine (0.21 g, 0.52 mL, 1.2 eq, 2.8 mmol) and triethylamine (0.37 g, 0.73 mL, 2.0 eq, 3.7 
mmol) were added to DCM (5.0 mL) at 0 °C under N2 gas and stirred for 5 minutes. Dansyl chloride, 46, 
(0.50 g, 1.0 eq, 1.9 mmol) was dissolved in DCM (5 mL) and added dropwise over 15 minutes to the 
reaction mixture. This was stirred for 1.5 hours at 0 °C. The reaction was then quenched with saturated 
NaCO3 (1.0 mL) and DCM (5.0 mL). Thereafter the organic layer was extracted with DCM (2 × 15 mL) 
and concentrated in vacuo. The yellow solution was dried using MgSO4, filtered and concentrated in vacuo. 
The crude material was purified using column chromatography with EtOAc:Hexane gradient starting at 
25% EtOAc was used as eluent to obtain the product (47), a yellow crystalline solid in a yield of 93% 
(0.51g). HRMS: calculated mass for C22H19NO9 [M+H] 295.1045; found 295.1114 m/z. 1H NMR (400 MHz, 
CDCl3) δ 8.56 (m, 1H, Ar), 8.32 – 8.23 (m, 2H, Ar), 7.56 (m, 2H, Ar), 7.20 (dd, J = 7.5, 0.9 Hz, 1H, Ar), 
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5.06 (m, J = 6.2 Hz, 1H, Ar), 3.61 (dd, J = 5.1 Hz, 2H, NCH2CH2), 3.09 – 3.00 (m, 2H, CH2CH3), 2.90 (s, 
6H, -N(CH3)2). 13C NMR and IR spectroscopy have been omitted as the product was sufficiently 
characterized for further use.  
Product 47 (75 mg, 1.2 eq, 0.25 mmol) and CBr4 (92 mg, 1.3 eq, 0.28 mmol) was added to DCM 
(2.0 mL) at 0 °C under N2. Triphenyl phosphine (74 mg, 1.3 eq, 0.28 mmol) in DCM (3 mL) was then 
added dropwise over 30 minutes. The reaction mixture was allowed to warm to room temperature while 
stirring for two hours. The crude mixture was concentrated in vacuo, hexane was added (10 mL), and the 
precipitate filtered off and washed with hexane. The elute was then concentrated in vacuo and purified 
using column chromatography with EtOAc:Hexane gradient starting at 25% EtOAc was used as eluent to 
obtain the product, a yellow oil, 48, in a yield of 31% (29 mg). This reaction was repeated on a scale 5 
times that of the initial experiment, yielding the product in 30% yield (0.14g) 
Compound 48 (0.12 g, 1.0 eq, 0.30 mmol) was then reacted with sodium azide (20 mg, 1.0 eq, 0.30 
mmol) in DMF for 5 hours starting at 0 °C and warming to room temperature under N2. The reaction was 
quenched by dissolution by the addition of water. The product was dried in vacuo at low temperature. The 
product was then purified using flash chromatography with DCM: MeOH as elute. A pale-yellow oil, 40, 
was obtained in a yield of 97% (31 mg). 
1H NMR (400 MHz, CDCl3) δ 8.58-8.55 (m, J = 8.5, 1.1 Hz, 1H, Ar), 8.32 – 8.23 (m, 2H, Ar), 
7.56 (m, 2H, Ar), 7.20 (dd, J = 7.5, 0.9 Hz, 1H, Ar), 5.06 (t, J = 6.2 Hz, 1H, -NH), 3.61 (dd, J = 5.1 Hz, 
2H,-NCH2CH2-), 3.09 – 3.00 (m, 2H, -NCH2CH2-), 2.90 (s, 6H, -N(CH3)2). 13C NMR (101 MHz, CDCl3) δ 
152.12, 134.46, 130.80, 129.96, 129.61, 129.48, 128.67, 123.14, 118.44, 115.37, 50.92, 45.39, 42.37. 
HRMS: calculated mass for C14H18N5O2S [M+H] 320.1181; found 320.1173 m/z. ATS FT-IR cm-1: 668, 
697, 952, 1019, 1310, 1406, 1436, 1661, 2913, 2995, 3441. Liquid at room temperature (25 °C). Confirmed 
by comparison to literature.64 
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 Synthesis of N-(3-azidopropyl)-5-(dimethylamino)naphthalene-1-sulfonamide (41) 
 
Scheme 21: Synthesis of product 41 from dansyl chloride 46  
1-Amino propanol (0.42 g, 0.42 mL, 1.5 eq, 5.5 mmol) and triethylamine (0.37 g, 0.56 mL, 2.0 eq, 
7.4 mmol) were added to DCM (5.0 mL) at 0 °C under N2 gas and stirred for 5 minutes. Dansyl chloride, 
46, (1.0 g, 1.0 eq, 3.7 mmol) was then dissolved in DCM (10 mL) and added dropwise over 15 minutes to 
the reaction mixture. This was stirred for 1.5 hours at 0 °C. The reaction was then quenched with saturated 
NaCO3 (1.0 mL) and DCM (5.0 mL). Thereafter the organic layer was extracted with DCM (2 × 15 mL) 
and concentrated in vacuo. The yellow solution was dried using MgSO4, filtered and concentrated in vacuo. 
The crude material was purified using column chromatography with an EtOAc:Hexane gradient starting at 
25% EtOAc as eluent to obtain the product (49), a yellow crystalline solid in a yield of 56% (0.65 g). 
HRMS: calculated mass for C15H21N2O3S [M+H] 309.1273; found 309.1277 m/z. ATS FT-IR cm-1: 682, 
734, 783, 796, 827, 837, 880, 900, 927, 947, 1058, 1072, 1110, 1145, 1161, 1197, 1231, 1314, 1355, 1404, 
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1451, 1462, 1480, 1588, 2788, 2828, 2929, 3157, 3496. The formation of the product was confirmed by 
TLC analysis. 
Product 49 (0.31 g, 1.0 eq, 1.0 mmol) and imidazole (0.10 g, 1.5 eq, 1.5 mmol) was added to DCM 
(2.0 mL) at 0 °C under N2. Triphenyl phosphine (0.39 g, 1.5 eq, 1.5 mmol) was added dropwise over ten 
minutes. Iodine (0.39 g, 1.5 eq, 1.5 mmol) was added to reaction mixture. The reaction was stirred for one 
hour at 0 °C. The reaction was quenched with saturated sodium thiosulfate (2.0 mL) and DCM(5.0 mL). 
The product was extracted with DCM (2 ×15 mL) and concentrated in vacuo and purified using column 
chromatography with EtOAc:Hexane gradient starting at 25% EtOAc was used as eluent to obtain the 
product(50), a yellow oil in a yield of 93% (0.39 g). C15H20N2O2S [M+H] 419.0290; found 419.0305 m/z 
for intermediate 50.  
Compound 50 (0.19 g, 1.0 eq, 0.44 mmol) was reacted with sodium azide (0.030 g, 1.0 eq, 0.44 
mmol) in DMF for 5 hours starting at 0 °C and warming to room temperature under N2. The reaction was 
quenched by dissolution and the addition of water (5.0 mL). The product was dried in vacuo at low 
temperature. The product was purified using flash chromatography with DCM: MeOH as elute. A pale-
yellow oil, 41, was obtained in a yield of 100% (0.15 g). 1H NMR (400 MHz, CDCl3) δ 8.56 (d, J = 8.5 Hz, 
1H, Ar), 8.30 – 8.22 (m, 2H, Ar), 7.56 (m, 2H, Ar), 7.20 (d, J = 7.5 Hz, 1H, Ar), 4.87 (t, J = 6.3 Hz, 1H, -
NHCH2), 3.26 (t, J = 6.4 Hz, 2H, -CH2CH2N3), 2.98 (dd, J = 6.4 Hz, 2H, -NHCH2CH2-), 2.89 (s, 6H, 
N(CH3)2), 1.66 (p, J = 6.5 Hz, 2H, -CH2CH2CH2-). 13C NMR (101 MHz, CDCl3) δ 152.15, 134.32, 130.64, 
129.94, 129.82, 129.52, 128.51, 123.19, 118.45, 115.26, 67.08, 48.77, 45.39, 40.81, 28.79. ATS FT-IR cm-
1: 668, 697, 952, 1019, 1310, 1406, 1436, 1661, 2913, 2995, 3441. MP: Oil at room temperature. Mass 
spectroscopy was not performed, due to 100% conversion of the starting material, confirmed by TLC, IR 
spectroscopy also indicates the presence of the azide. NMR analysis also compares favorably with those 
confirmed by literature for compound 40. 
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 Attempted Synthesis of (S)-2-azidoethyl 2-((tert-Butyldioxycarbonyl)amino)-3-phenylpropanoate 
(42) 
 
Scheme 22: Attempted method used for synthesis of compound 42  
d-tert-Butyl dicarbonate (0.22 g, 1.1 eq, 2.4 mmol) was added slowly to l-phenyl alanine(0.20 g, 
1.0 eq, 2.2 mmol) and sodium hydroxide (0.20 g, 2.2 eq, 4.9 mmol) and in a water: THF mixture (1:1 ratio, 
5.0 mL) and left to stir at room temperature for 12 hours. The reaction was quenched with a saturated 
sodium chloride solution (5.0 mL). The resultant mixture was concentrated in vacuo. The product was then 
recrystallized from water. HRMS: calculated mass for C14H20NO4 [M+H] 266.1392; found 266.1385 m/z. 
The Boc protected L-phenyl alanine (0.32 g, 1.0 eq, 1.2 mmol) was then dissolved in DMF (5 mL) 
and sodium hydride (0.03 g, 1.0 eq, 1.2 mmol) and 2-azidoethyl methyl sulfonate (0.20 g, 1.1 eq, 1.2 mmol) 
were added. This was stirred at room temperature for 20 minutes. The reaction was left to stir at 0 °C for 
24 hours. The reaction was quenched with saturated sodium chloride solution (5 mL). The mixture was 
concentrated under low temperature in vacuo and loaded onto silica. The crude material was purified using 
column chromatography with EtOAc:Hexane gradient starting at 20% EtOAc as eluent to obtain the 
unidentified, product a white solid in a yield of 95% approx. (0.48 g). 
1H NMR (400 MHz, CDCl3) δ 7.35 – 7.20 (m, 1H), 7.18 – 7.11 (m, 1H), 4.44 – 4.32 (m, 3H), 4.34 
(d, J = 4.2 Hz, 1H), 3.88 – 3.75 (m, 1H), 3.70 (s, 1H), 3.63 – 3.55 (m, 2H), 3.08 (s, 4H), 3.08 (s, 1H), 3.00 
(s, 1H), 1.40 (s, 4H), 13C NMR (100 MHz, CDCl3) δ 135.77, 129.23, 128.66, 127.18, 71.19, 68.92, 67.43, 
67.07, 62.54, 49.85, 37.77, 37.71, 28.25. Unfortunately, NMR spectroscopy indicates that the desired 
product was not synthesized. These values were compared to literature, indicting the absence of the desired 
product.71 Thus, further spectroscopic analysis and identification was not performed. This product was not 
used in the subsequent click reaction. 
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 Compound 43 and Compound 44  
These compounds were synthesized by a member of the Stellenbosch University Group of Organic 
and Medicinal Chemistry (GOMOC), Mr. MG Botes, and analysis aligns with expected literature values.  
 Synthesis of 1-(azidomethyl)-4-nitrobenzene (45) 
 
Scheme 23: Synthetic procedure used in the production of azide 45 
Sodium azide (0.13 g, 1.0 eq, 2.0 mmol) was added to 4-nitobenzyl bromide (0.43 g, 1.0 eq, 2.0 
mmol) in acetonitrile (5.0 mL) and stirred at room temperature for 5 hours under N2. The reaction was 
quenched with water (10 mL). The product was extracted using ethyl acetate (3 × 15 mL) and washed with 
a saturated sodium chloride solution (5.0 mL) and concentrated in vacuo. The crude material was purified 
using column chromatography, with an EtOAc:Hexane gradient starting at 5% EtOAc used as eluent, to 
obtain the product (45), a yellow oil in 99% yield (0.36 g). 1H NMR (400 MHz, CDCl3) δ 8.24 (dd, 2H, 
Ar), 7.54 – 7.46 (dd, 2H, Ar), 4.50 (s, 2H, -CH2N3). Confirmed by literature and TLC analysis.66 
 
 Click reactions 
The following section discusses the synthetic methods used to produce alkyne azide cycloaddition 
(click) products from the 4N-functionalized-aza-podophyllotoxin products 36a and 36b, synthesized in 
Library 1. This section will highlight the optimizations performed, as well as report the best yields obtained. 
Two general methods were used for the synthesis of the desired products, method A, without the use of a 
ligand and method B, using a THTPA ligand. Each method included a mild reducing agent, a copper catalyst, 
the specified azide, and either starting material 36a or 36b.  
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Figure 32: 4-Aza-podophylltoxin analogues attempted through click chemistry of azides 40-45 with 
products 36a an 36b  
 Synthesis of products 52a-56b 
This section is split into six parts, each part comprising of one of the click products. All products 
that were successfully made were synthesized using the general procedure (A). Each section also contains 
a table displaying the procedures attempted in that section. The products that are marked with an asterisk 
(* in tables) made use of procedure B. Where solvent mixtures have been indicated in the tables it should 
be assumed to be in a 1.3:1 ratio, unless otherwise stated. NMR analysis for this section will define peaks 
as Az (azide peaks) and Pod (Podophyllotoxin core structure). 
 General procedures A 
Azide 40-45 (1.0 eq, 0.1 mmol) and the copper catalyst (79 mg, 0.050 eq, 0.050 mmol) were added 
to a solvent (3.0 mL) at RT and allowed to dissolve. Product 36a/b, (1.0 eq, 0.10 mmol) and sodium L-
ascorbate were added (amount specified in Tables 10-14). The reaction was then stirred for 36 hours, after 
which the reaction was quenched with a saturated NH4Cl solution (2.0 mL) and water (1.0 mL). The 
resultant precipitate was obtained through filtration and washed with ethanol. The precipitate was dried in 
vacuo. 
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 General procedure B 
Prior to setting up the reaction, the “click”-precatalyst, CuSO4/THPTA, was pre-chelated for 10 
minutes by mixing aq. CuSO4.5H2O (20 μL, 8.0 μmol, 0.40 M, 0.050 eq) and aq. THPTA (40 μL, 8.0 μmol, 
0.20 M, 0.050 eq). Starting material 36a/b (0.10 mmol, 1.0 eq) and azide 40-45 (0.10 mmol, 1.0 eq) were 
dissolved in solvent (2.0 mL) and added to the reaction flask. Then the CuSO4/THPTA solution (60 μL, 8.0 
μmol, 0.13 M, 0.050 eq) was added. Lastly, aq. sodium L-ascorbate (40 μL, 32 μmol, 0.80 M, 0.20 eq) was 
added to the reaction mixture and it was stirred under N2 at room temperature for 36 hours. The reaction 
was next quenched with a saturated NH4Cl solution (2.0 mL) and water (1.0 mL). The resultant precipitate 
was obtained through filtration and washed with ethanol. The precipitate was dried in vacuo.  
The compound characterizations and reaction conditions that were variable for each individual 
product are shown below. 
 Synthesis of 52: 4N-aza-posophyllotoxin with fluorescent marker 40 
 
Figure 33: Expected structure of compound 52 synthesized from 36a/b and Azide 40. 
The best crude yield obtained was 55% (41 mg). No pure recovery of starting material or final 
product was achieved. 
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ascorbate (in eq.) 
52a DMSO  24 RT Cu(OAc)2 0.1 
52a DMF  24 RT Cu(OAc)2 0.1 
52a t-BuOH: 
H2O 
 24 RT Cu(OAc)2 0.1 
52a t-BuOH: 
H2O 
 24 RT Cu(SO4)∙5H2O  0.1 
52a DCM: H2O  6 RT Cu(SO4)∙5H2O 0.1 
52a DMSO  24 60 Cu(OAc)2 0.3 
52b DMSO  24 RT Cu(OAc)2 0.1 
52b DMSO  32 RT Cu(OAc)2 0.1 
52b DMSO  12 RT CuSO4  0.1 
52b DMF  24 RT CuSO4  0.1 
52b DCM: H2O  6 RT Cu(OAc)2 0.1 
52b DMSO  24 60 Cu(OAc)2 0.3 
52a* DMSO  24 RT Cu(SO4)∙5H2O  0.2 
52b* DMSO  24 RT Cu(SO4)∙5H2O  0.2 
 
3.3.2.4.1 Compound 52a 
Due to the impure nature of this product integration of the peaks for this spectrum are not consistent. 
Integration of this NMR indicates an overlap between peaks of the starting material and the final structure, 
in a minimum of a 1:5 final product to starting material ratio.  
1H NMR (600 MHz, DMSO-d6) δ 8.68 – 7.10 (m, 1H, Ar, Az), 7.01 – 6.92 (s, 1H, Ar, pod), 6.78 – 
6.71 (s, 1H, Ar, Pod), 6.44 – 6.41 (s, 1H, Ar, Pod), 6.08 – 5.91 (dd, 1H, Ar, Pod), 5.24 – 5.13 (d, 1H, Pod), 
5.04 – 4.92 (m, 1H, Pod), 4.63 – 4.58 (dd, 1H, Pod), 4.36 – 4.32 (t, 3H, Pod), 3.69 – 3.66 (s, 3H, Pod), 3.48 
– 3.38 (qd, 15H, Pod), 2.85 – 2.79 (s, 1H, Az, N(CH3)2), 1.85 (t, 0.1H, Az, CH2CH2N) 1.08 – 1.03 (t, 31H, 
Pod). 13C NMR (75 MHz, DMSO-d6) δ 172.27, 159.57, 153.28, 147.32, 144.09, 142.73, 136.55, 131.09, 
119.75, 110.27, 104.92, 101.98, 97.68, 97.07, 78.73, 76.16, 65.67, 60.33, 56.49, 56.28, 40.88, 36.12, 19.02. 
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IR spectrum showed insufficient material present at the time or testing. HRMS: calculated mass for 
C37H37N6O9S [M+H] 741.2343; found 741.2325 m/z. MP 184-186 °C. 
3.3.2.4.2 Compound 52b 
Compound 52b was not observed with NMR spectroscopy and the starting material was exclusively 
recovered. Recovery of 96% starting material (36b) was achieved (42 mg). 
 Compound 53: 4N-aza-podophyllotoxin with fluorescent marker 41 
 
Figure 34: Desired product 53 for the click reaction between compound 41 and 36a/b 
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Table 11: Methods used in the synthesis of products 53a and 53b 
Click 
Product 




Amount of sodium 
L-ascorbate(in eq.) 
53a DMSO 24 RT Cu(OAc)2 0.1 
53a DMF 24 RT Cu(OAc)2 0.1 
53a t-BuOH: 
H2O 
24 RT Cu(OAc)2 0.1 
53a t-BuOH: 
H2O 
24 RT Cu(SO4)∙5H2O 0.1 
53a DCM:H2O 6 RT Cu(SO4)∙5H2O  0,1 
53a DMSO 24 60 Cu(OAc)2 0.3 
53b DMSO 24 RT Cu(OAc)2 0.1 
53b DMSO 32 RT Cu(OAc)2 0.1 
53b DMSO 12 RT Cu(SO4)∙5H2O 0.1 
53b DMF 24 RT Cu(SO4)∙5H2O 0.1 
53b DCM: H2O 6 RT Cu(OAc)2 0,1 
53b DMSO 24 60 Cu(OAc)2 0.3 
 
No product was observed in 1H NMR spectrum despite multiple attempts. Starting materials 36a/b 
and 41 was exclusively recovered. 
 Compound 54: 4N-aza-podophyllotoxin with meta-benzylic acid  
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Table 12: Methods attempted in the synthesis of 54a and 54b 
Click 
Product 
Solvent Time Temperature Catalyst(s) Amount of sodium L-
ascorbate   (in eq.) 
54a DMSO 24 RT Cu(OAc)2-5% 0.1 
54a DMSO 24 60 Cu(OAc)2-5% 0.15 
54a DMSO 48 RT Cu(OAc)2-10% 0.5 
54a DMSO 48 60 Cu(OAc)2-10% 0.2 
54b DMSO 24 40 Cu(OAc)2-10% 0.3 
 
3.3.2.6.1 Compound 54a 
The best yield obtained was 68%. (41 mg). 
1H NMR (300 MHz, DMSO) δ, 9.12 (s, 1H, OH), 8.38-8.36 (m, J = 1.9 Hz, 1H, Az, Ar), 8.16 (ddd, 
J = 8.1, 2.4, 1.1 Hz, 1H, Ar, Az), 8.06-8.03 (m, J = 7.8, 1.3 Hz, 1H, Ar, Az), 7.75 (t, J = 7.9 Hz, 1H, Ar, 
Az), 7.11 (s, 1H, Ar, Pod), 6.74 (s, 1H, Ar, Pod), 6.47 (s, 2H, -OCH2-, Pod), 6.06 – 5.85 (m, 2H, Ar, Pod), 
5.48 – 5.26 (m, 1H, Pod), 5.21 (d, J = 16.6 Hz, 1H, Pod), 4.98 (d, J = 16.9 Hz, 1H, Pod), 4.86 (s, 1H, Pod), 
3.86 – 3.67 (m, 1H, Pod), 3.64 (s, 6H, Pod), 3.56 (s, 2H, Pod),2.09 (s, 2H, Az, NCH2-Ar). HRMS: calculated 
mass for C31H27N4O9 [M+H] 599.1778, found 599.1768 m/z. ATS FT-IR cm-1: Suggests degradation of 
synthesized product. MP 204-206°C. 
3.3.2.6.2 Compound 54b 
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 Compound 55: 4N-aza-podophyllotoxin with para-benzylic acid  
Table 13: Methods used in the attempted synthesis of 55a and 55b 
Click 
Product 
Solvents Time Temperature 
Catalyst(s) 
5% or 10% 
Amount of 
sodium L-
ascorbate (in eq.) 
Yield 
in % 
55a DMSO 24h RT Cu(OAc)2 0.1 - 
55a t-BuOH: H2O 24h RT Cu(SO4)∙5H2O  0.3 - 
55a DMSO 24h RT Cu(OAc)2 0.1 - 
55b DMSO 24h 40 Cu(OAc)2 0.1 - 
55b DMSO 24h RT Cu(OAc)2 0.3 10 
55b DMSO 24h 60 Cu(OAc)2-10% 0.5 - 
55a* t-BuOH: 
H2O 
24h RT Cu(SO4)∙5H2O  0.2 65 
55b* t-BuOH: H2O 24h RT Cu(SO4)∙5H2O  0.2 20 
 
3.3.2.7.1 Compound 55a 
Initially it was thought that 65% yield (39 mg) was obtained, based on NMR spectroscopy, however 
mass spectroscopy did not correlate with the expected value. This suggests that what was thought to be the 
final product was actually a 1:1 mixture of the starting materials, or that an unknown reaction to form a side 
product took place.  
1H NMR (600 MHz, DMSO-d6) δ 8.40 – 8.30 (s, 1H, Ar, Az), 8.20 – 8.05 (m, 2H, Ar, Az), 7.81 – 
7.69 (t, J = 7.5 Hz, 1H, Ar, Az), 7.16 – 6.98 (d, J = 63.5 Hz, 1H, Ar, Pod), 6.79 – 6.69 (d, J = 34.7 Hz, 1H, 
Ar, Pod), 6.48 – 6.34 (d, J = 6.6 Hz, 2H, -OCH2O-), 6.07 – 5.81 (m, 2H, Ar Pod), 5.41 – 5.35 (d, J = 15.8 
Hz, 1H, Pod), 5.29 – 5.16 (dd, J = 37.3, 16.1 Hz, 2H, pod), 5.01 – 4.94 (dd, J = 16.4, 9.0 Hz, 1H, Pod), 4.84 
– 4.70 (d, J = 3.7 Hz, 1H, Pod), 4.67 – 4.56 (m, 1H, Pod), 3.74 – 3.66 (s, 2H, Pod), 3.68 – 3.56 (s, 6H, Pod), 
2.12 – 2.05 (s, 2H, Az), 2.00 – 1.97 (s, 1H, Pod), 1.19 – 1.14 (t, J = 7.1 Hz, 1H, Pod). 13C NMR (101 MHz, 
DMSO-d6) δ 206.69, 171.98, 170.54, 159.30, 153.01, 147.06, 143.82, 142.45, 136.28, 130.83, 119.47, 
109.99, 104.66, 101.71, 97.41, 96.80, 78.46, 75.90, 65.39, 62.99, 60.06, 59.95, 56.01, 35.85, 30.89, 20.96, 
14.28.HRMS: calculated mass for C30H23N4O9 [M+H] 583.1465 -found 583.1464 m/z. ATS FT-IR cm-1: 
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685, 705, 756, 791, 828, 874, 935, 1015, 1044, 1112, 1203, 1238, 1276, 1320, 1361, 1434, 1477, 1508, 
1608, 1643, 1726, 2114, 2900, 3246. MP:190-192 °C. 
3.3.2.7.2 Compound 55b 
A mixture of products was present in the mass spectrum. Peaks appeared at 871.2703 m/z, and 
436.1391 m/z. These values correspond with THPTA (2M+H) and the starting material, compound 36b.  
 Compound 56: 4N-aza-podophyllotoxin with 4-nitrobenzene  
 
Figure 36: Structure of product 56 from azide 45 and 4-aza-podophylltoixn derivatives 36a/b. 
The best yields obtained were 97% (58 mg) for 56a and 65% (40mg) for 56b 
 
Table 14: Methods used to synthesize 56a and 56b 
Click 
Product 








56a* t-BuOH: H2O 24h RT Cu(SO4)∙5H2O  0.2 75 
56a* DMSO 24h RT Cu(SO4)∙5H2O  0.2 97 
56b* t-BuOH: H2O 2h RT Cu(SO4)∙5H2O  0.2 65 
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3.3.2.8.1 Compound 56a 
1H NMR (400 MHz, DMSO-d6) δ 8.32 (s, 1H, OH), 8.25 – 8.11 (m, 2H, Ar, Az), 8.09 (s, 1H, Az, 
Ar), 7.53 – 7.44 (m, 2H, Ar, Az), 7.02 (s, 1H, Ar, Pod), 6.69 (s, 1H, Ar, Pod), 6.40 (s, 2H, -OCH2O-), 5.94 
(s, 1H Ar, Pod), 5.92 – 5.84 (m, 1H, Pod), 5.76 (s, 2H, Pod), 5.28 (d, J = 15.9 Hz, 1H, Pod), 5.17 (d, J = 
15.7 Hz, 1H, Pod), 5.08 (d, J = 16.8 Hz, 1H, Pod), 4.87 (d, J = 17.0 Hz, 1H, Pod), 4.75 (s, 1H), 3.62 (s, 
6H), 3.69 – 3.52 (m, 1H), 2.02 (s, 2H, Az), 1.15 (q, J = 6.3, 5.5 Hz, 1H, Pod). 13C NMR (75 MHz, DMSO-
d6) δ 208.63, 206.81, 172.27, 170.52, 159.61, 147.92, 147.75, 147.35, 146.72, 143.39, 142.64, 137.51, 
134.20, 130.63, 129.29, 129.14, 128.85, 124.38, 124.05, 123.98, 123.96, 119.85, 110.06, 104.85, 101.43, 
96.39, 96.28, 68.64, 65.78, 59.88, 56.19, 56.14, 55.99, 55.98, 55.89, 52.04, 48.69, 32.20, 30.78, 29.66, 
20.85, 14.17.HRMS: calculated mass for C30H26N5O9 [M+H] 600.1731-found 600.1743 m/z. ATS FT-IR 
cm-1: 686, 731, 791, 859, 930, 1037, 1113, 1199, 1241, 1276, 1354, 1426, 1473, 1508, 1649, 1727, 2359, 
2941, 3484. MP: 196-198 °C. 
3.3.2.8.2 Compound 56b 
1H NMR (400 MHz, DMSO-d6) δ 8.32 (s, 1H, Ar, Az), 8.27 – 8.16 (m, 2H, Ar Az), 7.48 (d, J = 
8.4 Hz, 1H, Ar, Az), 7.01 (d, J = 19.8 Hz, 1H, Pod), 6.75 (d, J = 21.9 Hz, 1H, Pod), 6.46 (s, 2H, Pod), 6.03 
– 5.85 (m, 2H, Pod), 5.76 (s, 1H, Pod), 5.34 – 5.19 (m, 1H, Pod), 5.19 – 5.05 (m, 1H, Pod), 4.91 (m, 1H, 
Pod), 4.82 (d, J = 5.6 Hz, 1H, Pod), 4.69 – 4.50 (m, 1H, Pod), 3.66 (d, J = 14.4 Hz, 6H, Pod), 3.57 (d, J = 
6.9 Hz, 3H, Pod), 3.31 (s, 2H, Pod), 2.06 (s, 1H, Az), 1.97 (s, 1H, Az), 1.15 (t, J = 7.1 Hz, 1H, Pod). 13C 
NMR (75 MHz, DMSO-d6) δ 172.56, 172.29, 170.80, 159.93, 159.35, 148.36, 148.30, 147.73, 147.18, 
147.10, 144.01, 143.79, 143.75, 143.02, 137.85, 137.39, 134.78, 134.60, 131.05, 131.03, 129.64, 129.50, 
124.74, 124.43, 124.36, 120.21, 110.43, 110.28, 105.26, 101.91, 101.79, 97.93, 96.96, 96.77, 96.66, 78.76, 
76.13, 66.13, 60.22, 56.49, 56.46, 56.40, 56.36, 52.39, 36.09, 31.15, 21.51, 21.22, 19.02, 14.55. HRMS: 
calculated mass for C31H28N5O9 [M+H] 614.1887-found 614.1883 m/z. ATS FT-IR cm-1: 686, 707, 732, 
764, 790, 813, 836 ,863, 925, 975, 925, 975, 1020, 1046 , 1125, 1201, 1236, 1350, 1423, 1476, 1503, 1525, 
1588, 1611, 1647, 1727, 2107, 2940, 3219. MP: 196-198 °C. 
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 Chapter 4 Biological activity 
4.1 Introduction 
(-) Podophyllotoxin, the naturally occurring cyclolignan, has shown significant biological activity 
against a number of diseases, its most significant use is as an anti-cancer agent. Seven of its semisynthetic 
analogues have made it into clinical trials or are currently in use as anticancer agents.1  These are etoposide 
(9), teniposide (10), etopophos (currently in use1), NK-611 (12), GL331 (14), NPF (13), and TOP53 (15) 
(currently in clinical trials, see Figure 37).1 Etoposide (aka Vepesid®, 9), its prodrug etopophos (11), and 
teniposide (10) are commercially used and approved by the FDA as anticancer agents.6,36 Podophyllotoxin 
and its analogues have also been approved as antivirals (mainly for treatment of the human papilloma virus 
(HPV), in dermatology (for the treatment of venereal warts), as vascular disrupting agents, and as an 
arthritis medication.27 Podophyllotoxin analogues have been extensively used to treat Wilms tumors, non-
Hodgkin and other lymphomas, colon and lung cancer.17  
The semi-synthetic analogues (9-15) all show the same stereomeric form at C1 form which has 
been found to be the more active of the two enantiomers (the R enantiomer is active, while the S is not with 
regards to the C1 position, see Figure 37, structure 9). The stereochemistry of the C4 position in the 
biologically active semi-synthetics is opposite to that of naturally occurring (-)-podophyllotoxin.1 Research 
done by Magedov et al.8 found that the optical antipode of 4-aza-podophylltoxin analogues formed through 
MCR, that match naturally occurring podophyllotoxin show significantly heightened biological activity 
when compared to their S enantiomeric counterpart in relation to the C1 position.17 That said, there is little 
evidence suggesting that a mixture of the two diastereomers will lead to either synergistic or anti-synergistic 
effects. Therefore, in this project the individual isomers were not isolated, and a mixture of the enantiomers 
was used in the subsequent biological testing.  
Natural podophyllotoxin and etoposide show IC50 values of between 0.076 and 0.05 µM against 
HeLa and KB cell lines, which is similarly reported for the 4-aza-podophyllotoxin analogues.1 Detailed 
information on the various IC50 values have been reviewed by Yu et al.(2017).1 For the 4-aza-podphylltoxin 
analogues, IC50 values of below 3 µM were obtained against several cell lines, with most being in nM range 
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against HeLa, B16, A549 and other cell lines.1 There have not been any reported cases of testing against 
esophageal and other cell lines. This motivated the biological testing, the results of which are presented in 
this chapter.  
              
                           9                                10                   11 
                             
                      12            13         14 
                                                     
                  15 
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Figure 37: The structures of Etoposide (9), Teniposide (10), Etopophos (11), NK-611(12), NFP 
(13), GL331(14) and TOP53 (15) 
The experiments undertaken in this part of the project were focused on compounds synthesized in 
the first library, specifically: 33a/b, 34a, 35a, 36a/b, 37a/b and 38a/b, shown in Figure 38 below. 
 
Figure 38: The compounds sent for biological testing, all from Library 1. *3 
Compound 35a has been included in the set of compounds that were biologically tested despite 
their lack of correlation with literature-based analysis of 1H NMR spectroscopy and mass spectral data. 
This chapter will begin by outlining the biological testing performed by the author with the 
assistance of the GOMOC and the Stellenbosch University Department of Physiology under the direction 
of Dr CH Kaschula. It then presents the preliminary testing undertaken by our collaborators at Youngstown 
State University (YSU). This is followed by a section outlining the experiments performed using MTT cell 
line assays in the Department of physiology at Stellenbosch University. It concludes by presenting the 
 
 
*3 These compounds were tested both by our group (GOMOC) and our collaborators in the USA. 
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summarized findings. The IC50 values reported in this chapter come from at least three data sets, each run-
in triplicate. The data sets have also been modified to exclude outlying data points. 
4.2 Results and discussion 
  Testing by GOMOC 
 
Figure 39: Products tested by GOMOC against the WHCO1 cell line assay*4 
The biological testing of the of compounds shown in Figure 39 present a clear trend; compounds 
with the methoxy functionality in the R2 position were more biologically active than those with phenolic 
functional group.  This is most likely be due to an interaction between the tubulin binding site and lower E 
ring. We further stipulate that the methoxy functionality binds more efficiently to the phenolic moiety.1 The 
IC50 values obtained for the WHCO 1 cell line also indicate that the unfunctionalized compounds (38a/b) 
show the greatest activity. Compounds 38a and 38b, displayed IC50 values of 42 ± 20 nM and 20 ± 11 nM 
respectively. These compounds were found to be significantly more active. The results of the preliminary 
 
 
*4 The compounds from Library 1 not shown in Figure 21 were not synthesized in time for biological testing i.e. compounds 36a/b and 37a/b. 
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testing fall within the nM IC50 value ranges observed by Magedov et al. for the unfunctionalized 4-aza-
podophyllotoxin compounds.8  
 
Graph 1: IC50
 values obtained for the compounds tested from Library 1 (see Figure 39). Values 
obtained from GOMOC, tested against a WHCO1 esophageal cell line assay. 
The compounds with propargyl groups in the R1 position (36a and 36b) were the next most active 
compounds, with IC50 values of 143 ± 60 and 125 ± 28 nM. Those with ester functionalities showed the 
second lowest activity, though still in the nM range (33a, 33b and 34a). Of the three, the lowest IC50 value 
was for 33b with an IC50 of 143 ± 18 nM, which falls in the same range as 36a and 36b. Finally, compound 
35a, showed little to no activity when compared to the other compounds in this data set. This further justifies 
the conclusion that compound 35a does not conform to the 4-aza-podophylltoxin structure. The moderate 
activity of compounds 36a and 36b inspired the further generation of compounds with a triazole 
functionality (Library 2) via a click reaction approach. In our opinion, the propargyl groups also showed 
the best potential for further functionalization in a way that would not impact the core 4-aza-
podophyllotoxin structure. The results were within our expectation, with biological activity in a >500 nM 


































COMPOUNDS TESTED FROM LIBRARY 1, SHOWN IN FIGURE 12
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 Preliminary testing by Youngstown State University 
The following preliminary results were obtained from our YSU collaborators in the USA. 
Compounds from library 1 were tested against a skin (SK-Mel-28), a lung (A549), and two breast (MDA-
MB-231 and MCF7) cancer cell lines.  
 
 
Figure 40: Products from Library 1 tested by our collaborators at YSU. 
Table 15: IC50 raw data obtained from YSU for compounds 33a, 34a, 36a, 37a, 37b; naturally-
occurring podophyllotoxin and anticancer agent camptothecin, when tested against cell line assays.  
Product IC50 values obtained in nM  
Cell line: MDA-MB-231 SK-MEL-28 MCF7 A549 
33a 27±24.0 29.7±24.2 >100 >100 
34a 6.6±3.2 12.7±6.4 >100 >100 
36a <10 7.3±0.6 >100 >100 
37a - 10-50* >100 >100 
37b 18.5 ± 12.021 10-100* >100 >100 
Podophyllotoxin <10 <10 ~ 10 ~ 10 
Camptothecin <10 <10 ~10 ~10 
 
Despite the compounds from Figure 40 having been sent to YSU in April 2019, by December the 
results obtained were unfortunately preliminary in nature (see Table 15). Therefore, no firm predictions 
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can be made from this data set. This data set does appear to follow the general trend obtained by GOMOC. 
The YSU data set shows that compound 36a is, on average, comparatively more active than compound 33a 
in the SK-MEL-28 cell line. From the table, compound 34a is slightly more active than compound 33a, as 
was observed in the previous data set. 
The IC50 values were observed when comparing 33a and 34a do not indicate improved selectivity 
of the longer chain ester moiety for the cell lines SK-MEL-28 and MDA-MB-231, due to the preliminary 
nature of the testing, but do indicate superior activity is exhibited by 34a. Compounds 33a and 34a do show 
very slightly improved activity against the MDA-MB-231 cell line compared to the SK-MEL-28 cancer 
cell line. Lower IC50 values are consistently observed for 34a compared to 33a over all cell lines, further 
indicating improved activity for the compounds with an extra CH2 group (34a/b). The GL331 (14) inspired 
compounds 37a and 37b, despite not having obtained reproducible data, show biological activity against 
the SK-MEL-28 cell line, indicated with an asterisk (*) in Table 15. Unfortunately, accurate data could not 
be obtained for the MCF7 and A549 cancer cell lines due to reduced cell viability, with only 55-60% of the 
cells showing viability, making results inconclusive. The data for these two cell lines do, however, indicate 
initial activity of a factor of 10 lower than that of the naturally occurring podophyllotoxin. Our collaborators 
in the USA are currently repeating the experiment, and we hope to have this data in due course. The IC50 
values for the WHCO1 cancer cell line (ranging from 125-500 nM for the same compounds) were on 
average higher than those obtained for the SK-MEL-28 and MDA-MB-231 cancer cell lines (ranging from 
7-30 nM). These results suggest that focus should be placed on the SK-MEL-28 and MDA-MB-231 cancer 
cell lines in the future. 
4.3 Conclusions 
The preliminary biological data shows two significant trends. First, that the compounds from 
Library 1 show biological activity against a range of cancer cell lines (with the exception of 35a), with IC50 
values comparable to naturally-occurring podophyllotoxin, and other podophyllotoxin analogues. Second, 
those compounds with a methoxy moiety in the R2 position were on average more active than those with 
phenolic functionalities. The initial WHCO1 cancer cell line assay results indicate that compounds 38a and 
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38b showed the most biological activity. Both data sets also indicate that the ester (33 and 34) and propargyl 
4N-functionalized compounds from Library 1 show similar activity across all cell lines. Finally, compound 
33a is typically less active than 34a, indicating that lengthening the ester moiety may improve biological 
activity. Future work will include obtaining reproducible data for all cell lines, with focus being placed on 
compounds 37a and 37b and the SK-MEL-28 and MDA-MB-231 for comparison against GL331 (14). 
4.4 Experiments performed using the MTT cell line assay 
 Cell growth conditions 
All WHCO1 cells were grown in the laboratory of the Stellenbosch Physiology Department. 
The WHCO1 cell line (esophageal cancer cells, of South African origin), was derived from a biopsy 
of primary esophageal squamous cell carcinoma. Cells were all incubated at 37 °C under 5% CO2 (the cells 
were split every three days) and cultured with antibiotics in DMEM (Dulbecco's Modified Eagle Medium) 
containing 10% FBS (Foetal Bovine Serum, Gibco, Life Technologies, South Africa). 
 Cell Cytotoxicity Assay 
The cytotoxicity of the 4-aza-podophyllotoxin analogues (33-38) were quantified using the 
standard MTT cellular viability assay. Briefly, WHCO1 oesophageal cancer cells were seeded at a density 
of 2.5 × 1030 cells per well in 90 µL DMEM growth media, supplemented with 10% FBS and 2% 
penicillin/streptomycin in a 96-well culture dish. The cells were allowed to attach overnight. The following 
day 10 µL of 2-fold dilutions (0 - 800 nM) of the 4-aza-podophylltoxin analogue (previously specified) in 
DMSO (0.2% v/v) was added in triplicate to the cells and incubated for 48 hours. Thereafter, 10 μL of 5 
mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma-Aldrich) was added 
and incubated with the cells for 4 h. The resulting formazan crystals were solubilised by adding 100 μL of 
10% sodium dodecyl sulphate (Sigma-Aldrich) to each well and incubated overnight at 37 °C. The 
absorbance at 595 nm was measured using a Multiskan FC multi-well reader and the data was fitted using 
Graphpad prism v5 using log (inhibitor) vs response (variable slope) from which a cytotoxicity IC50 value 
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was obtained. All compounds were tested independently, more than three times, from which an average 




*5The work done for the experiments for this chapter was split between the author and Dr CH Kaschula, with the assistance of members of GOMOC under 
the supervision of Dr Kaschua. 
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 Chapter 5 Conclusions and future work 
5.1 Conclusions  
The aims of this research were first to synthesize a diverse library of modified 4-aza-
podophyllotoxin-analogues through a set of multicomponent reactions to further investigate structure 
activity relationships. The second aim was to add biologically active moieties to the 4-N position of the 
newly synthesized analogues that can selectively target cancer cells, or act as phosphorescent markers. It 
was also hoped that these modified compounds would hold increased selectivity for cancer cells, while 
reducing toxicity to human cells, a goal which has not been achieved due to a lack of biological date. The 
challenges faced during synthesis further contributed to the lack of further data.  
Twelve unique 4-aza-podophylltoxin analogues were successfully synthesized for Library 1 from 
the initially reported 6 N-functionalized anilines. Though other anilines were synthesized in this project, 
they did not yield the desired 4-aza-podophyllotoxin analogues in yields sufficient for analysis. For Library 
1 most products were synthesized in yields below 50%. The reactions that made use of microwave 
irradiation and 4-chloroaniline provided more significant yields. It was also proven that the products from 
Library 1 can undergo further functionalization without affecting the central 4-aza-podoophylltoxin 
scaffold. The 4N-functionlaised 4-aza-podophylltoxin analogues from Library 1 were all synthesized in 
yields sufficient for further analysis. Of these 12 compounds, six contained the phenolic group in the R2 
position and six the methoxy moiety, making them ideal for comparative analysis.  
The biological data for Library 1 shows two significant trends. First, that the compounds show 
biological activity against a range of cancer cell lines (with the exception of 35a), with IC50 values in the 
normal range comparable to naturally occurring podophyllotoxin. Second, those compounds with a 
methoxy moiety in the R2 position are on average more active than those with phenolic functionalities. The 
WHCO1 cancer cell line assay results indicate that compounds 38a and 38b show the most biological 
activity. Both data sets, from YSU and GOMOC, also indicate that the ester (33 and 34) and propargyl 4N-
functionalized compounds form Library 1 show nM activity across all cell lines. Finally, compound 33a is 
typically less active than 34a, indicating that lengthening the ester moiety may improve biological activity.  
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Four compounds were successfully synthesized for Library 2 but require further purification before 
biological testing. Of these, three contain the phenolic moiety in the R2 position and one contains the 
methoxy moiety in the R2 position. One analogue was successfully coupled to a fluorescent marker, making 
it ideal for further biological testing. It was observed that the click reactions which employed THPTA as a 
ligand performed significantly better than those that did not.  
It has been shown that the synthesis of the compounds from Library 1 and 2 is reproducible, making 
them ideal for further study. Of the compounds synthesized in Library 1, most show biological activity in 
the nM range against an esophageal cell line, showing activity comparable to naturally occurring 
podophyllotoxin. 
5.2 Future work  
Future work will revolve around the synthesis of the missing compounds, 35a/b from Library 1 
and 52b, 53a, 53b, 54b, 55a and 55b from Library 2. The synthesis of 35a and 35b will revolve around the 
optimization of the synthesis of the precursor amine via ethanolamine, or the synthesis of an azide that will 
result in a terminal amine being produced after the copper catalyzed azide alkyne cycloaddition. For the 
unsuccessful cycloaddition reactions further exploration into potential reaction conditions will be done i.e. 
the use of DMSO as well as increasing heat without degrading the starting material. Focus will need to be 
placed on the compounds from Library 2 as the procedures for the synthesis of these compounds has been 
thoroughly explored and assist in the generation of a large group of diverse 4-aza-podophylltoxin analogues. 
 Biological testing of 37a and 37b against the SK-MEL-28 and MDA-MB-231 cancer cell lines for 
comparison against GL331 (14) will also be undertaken. 
Significant work will need to be done into the isolation of the enantiomers to further support the 
work done by Magedov et al.8 Improved isolation methods for the products obtained in this project will 
also need to be developed. Though DCM: methanol, or acetonitrile: water column chromatographic 
separations are effective for isolation of the MCR products are racemic mixtures, chiral stationary phase 
chromatography will be required to obtain the isolated enantiomers. 
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The overall yields of the products obtained (as discussed in Chapter 2) were not sufficient for 
significant biological testing. Therefore, further optimization of the reaction conditions will be required. 
Exploration of enantiomeric selectivity during the ring closure reaction should also be explored. If it is 
possible to selectively make the R enantiomer, more accurate biological data can be obtained.   
The further modification of compounds 34 and 37 after the MCR should also be further explored, 
with specific focus placed on the reduction of the nitro moieties without affecting the central scaffold.  
Other cell lines should also be investigated to test for selectivity, most importantly the impacts of 
these agents on healthy cell lines. Confocal microscopy should also be used in order to observe the target 
site of the fluorescent labeled compounds.  
  
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 114 
 Bibliography 
(1)  Yu, X.; Che, Z.; Xu, H. Recent Advances in the Chemistry and Biology of Podophyllotoxins. Chem. 
- Eur. J. 2017, 23 (19), 4467–4526. https://doi.org/10.1002/chem.201602472. 
(2)  Eyberger, A. L.; Dondapati, R.; Porter, J. R. Endophyte Fungal Isolates from Podophyllum 
Peltatum Produce Podophyllotoxin. J. Nat. Prod. 2006, 69 (8), 1121–1124. 
https://doi.org/10.1021/np060174f. 
(3)  Imbert, T. F. Discovery of Podophyllotoxins. Biochimie. 1998, 80 (3), 207–222. 
https://doi.org/10.1016/S0300-9084(98)80004-7. 
(4)  Lu, Y.; Chen, J.; Xiao, M.; Li, W.; Miller, D. D. An Overview of Tubulin Inhibitors That Interact 
with the Colchicine Binding Site. Pharm. Res. 2012, 29 (11), 2943–2971. 
https://doi.org/10.1007/s11095-012-0828-z. 
(5)  Baldwin, E. L.; Osheroff, N. Etoposide, Topoisomerase II and Cancer. Curr. Med. Chem. Anticancer. 
Agents. 2005, 5 (615), 363–372. https://doi.org/10.2174/1568011054222364. 
(6)  Hande, K. R. Etoposide: Four Decades of Development of a Topoisomerase II Inhibitor. Eur. J. 
Cancer 1998, 34 (10), 1514–1521. https://doi.org/10.1016/S0959-8049(98)00228-7. 
(7)  Botes, M. G.; Pelly, S. C.; Blackie, M. A. L.; Kornienko, A.; van Otterlo, W. A. L. Synthesis of 4-
Azapodophyllotoxins with Anticancer Activity by Multicomponent Reactions (Review). Chem. 
Heterocycl. Compd. 2014, 50 (2), 119–138. https://doi.org/10.1007/10593.1573-8353. 
(8)  Magedov, I. V; Frolova, L.; Manpadi, M.; Bhoga, U. D.; Tang, H.; Evdokimov, N. M.; George, O.; 
Hadje Georgiou, K.; Renner, S.; Getlik, M.; , M.; Magedov, Igor V; Kinnibrugh, T. L.; Fernandes, 
M. A.; van Slambrouck, S.; Steelant, W. F. A.; Shuster, C. B.; Rogelj, S.; van Otterlo, W. A. L.; 
Kornienko, A. Anticancer Properties of an Important Drug Lead Podophyllotoxin Can Be Efficiently 
Mimicked by Diverse Heterocyclic Scaffolds Accessible via One-Step Synthesis. J. Med. Chem. 
2011, 54 (12), 4234–4246. https://doi.org/10.1021/jm200410r. 
(9)  World Health Organization. Cancer Factsheet. 2018. Accessed from https://www.who.int/news-
room/fact-sheets/detail/cancer. Last accessed 31 December 2019. 
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 115 
 (10)  Bjorkling, F.; Jensen, L. H. Anticancer Agents. In Textbook of Drug Design and Discovery; 
Krogsgaard-Larsen, P., Stromgaard, K., Madesen, U., Eds.; CRC Press: Boca Raton, 2010; 375–
392. 
(11)  Hanahan, D.; Weinberg, R. A. The Hallmarks of Cancer Review. Cell 2000, 100, 57–70. 
https://doi.org/10.1016/s0092-8674(00)81683-9. 
(12)  Carter, G. T. Natural Products in Drug Discovery. In Textbook of Drug Design and Discovery; 
Krogsgaard-Larsen, P., Stromgaard, K., Madesen, U., Eds.; CRC Press: Boca Raton, 2010; 89–105. 
(13)  Hainaut, P.; Plymoth, A. Targeting the Hallmarks of Cancer. Curr. Opin. Oncol. 2013, 25 (1), 50–
51. https://doi.org/10.1097/CCO.0b013e32835b651e. 
(14)  Todd, A.; Groundwater, P. W.; Gill, J. H. Anticancer Therapeutics, 1st ed.; Wiley: West Sussex, 
UK, 2018. https://doi.org/10.1002/9780470697047. 
(15)  Ahluwalia, V. K.; Chorpara, M. Cancer Chemotherapy. In Medicinal Chemisty; CRC Press: Broken 
Sound Parkway, NW, 2008; 239–264. 
(16)  All Nobel Laureates 2018. Norwegan Nobel Institute. 2018. Accessed from 
https://www.nobelprize.org/list-of-2018-nobel-laureates. Last accessed Dec 26, 2019. 
(17)  Magedov, I. V; Manpadi, M.; van Slambrouck, S.; Steelant, W. F. A.; Rozhkova, E.; Przheval’skii, 
N. M.; Rogelj, S.; Kornienko, A. Discovery and Investigation of Antiproliferative and Apoptosis-
Inducing Properties of New Heterocyclic Podophyllotoxin Analogues Accessible by a One-Step 
Multicomponent Synthesis. J. Med. Chem. 2007, 50 (21), 5183–5192. 
https://doi.org/10.1021/jm070528f. 
(18)  Solecki, R. S. Shanidar IV, a Neanderthal Flower Burial in Northern Iraq. Science. 1975, 190 (4217), 
880–881. https://doi.org/10.1126/science.190.4217.880. 
(19)  Ji, H.-F.; Li, X.-J.; Zhang, H.-Y. Natural Products and Drug Discovery: Can Thousands of Years of 
Ancient Medical Knowledge Lead Us to New and Powerful Drug Combinations in the Fight against 
Cancer and Dementia? EMBO Rep. 2009, 10 (3), 194–200. 
(20)  Krogsgaard-Larsen, P.; Stromsgaard, K.; Madsen, U. Introduction to Drug Design and Discovery. 
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 116 
In Textbook of Drug Design and Discovery; Krogsgaard-Larsen, P., Stromsgaard, K., Madsen, U., 
Eds.; CRC Press, 2010; 1–14. 
(21)  Ahluwalia, V. K.; Chorpara, M. Natural Products and Drug Development. In Medicinal Chemisty; 
CRC Press: Broken Sound Parkway, NW, 2008; 97–108. 
(22)  Dias, D. A.; Urban, S.; Roessner, U. A Historical Overview of Natural Products in Drug Discovery. 
Metabolites 2012, 2, 303–336. https://doi.org/10.3390/metabo2020303. 
(23)  Cragg, G. M.; Kingston, D. G. I.; Newman, D. J. Introduction. In Anticancer Agents from Natural 
Products; CRC Press: Boca Raton. 2005; 1–3. 
(24)  Mounia, G.; Zhen-zhou, J.; Lu-yong, Z. Podophyllotoxin , a Medicinal Agent of Plant Origin : 
Past , Present and Future. Chin. J. Nat. Med. 2012, 10 (3), 161–169. 
https://doi.org/10.3724/SP.J.1009.2012.00161. 
(25)  Gupta, C.; Prakash, D.; Gupta, S. A Biotechnological Approach to Microbial Based Perfumes and 
Flavours. J. Microbiol. Exp. 2015, (1), 34. https://doi.org/10.15406/jmen.2015.01.00034. 
(26)  Newman, D. J.; Cragg, G. M.; Snader, K. M. Natural Products as Sources of New Drugs over the 
Period 1981-2002. J. Nat.Prod. 2003, 1022–1037. https://doi.org/10.1021/np030096l. 
(27)  Gordaliza, M. Natural Products as Leads to Anticancer Drugs. Clin. Transl. Oncol. 2007, 9 (12), 
767–776. https://doi.org/10.1007/s12094-007-0138-9. 
(28)  Nguyen, K. T. Targeted Nanoparticles for Cancer Therapy: Promises and Challenges. J. Nanomed. 
Nanotechnol. 2011, 2 (5), 1–2. https://doi.org/10.4172/2157-7439.1000103e. 
(29)  Wu, Q.; Yuan, H.; Zhang, L.; Zhang, Y. Recent Advances on Multidimensional Liquid 
Chromatography-Mass Spectrometry for Proteomics: From Qualitative to Quantitative Analysis-A 
Review. Anal. Chim. Acta 2012, 731, 1–10. https://doi.org/10.1016/j.aca.2012.04.010. 
(30)  Willemse, C. M.; Stander, M. A.; Tredoux, A. G. J.; de Villiers, A. Comprehensive Two-
Dimensional Liquid Chromatographic Analysis of Anthocyanins. J. Chromatogr. A. 2014, 1359, 
189–201. https://doi.org/10.1016/j.chroma.2014.07.044. 
(31)  Chin, S. T.; Eyres, G. T.; Marriott, P. J. System Design for Integrated Comprehensive and 
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 117 
Multidimensional Gas Chromatography with Mass Spectrometry and Olfactometry. Anal. Chem. 
2012, 84 (21), 9154–9162. https://doi.org/10.1021/ac301847y. 
(32)  Chaudhary, D. K.; Khulan, A.; Kim, J. Development of a Novel Cultivation Technique for 
Uncultured Soil Bacteria. Sci. Rep. 2019, 9 (1). https://doi.org/10.1038/s41598-019-43182-x. 
(33)  Whisner, C. M.; Athena Aktipis, C. The Role of the Microbiome in Cancer Initiation and 
Progression: How Microbes and Cancer Cells Utilize Excess Energy and Promote One Another’s 
Growth. Curr. Nutr. Rep. 2019, 8 (1), 42–51. https://doi.org/10.1007/s13668-019-0257-2. 
(34)  Yadav, A. A.; Chee, G. L.; Wu, X.; Patel, D.; Yalowich, J. C.; Hasinoff, B. B. Structure-Based 
Design, Synthesis and Biological Testing of Piperazine-Linked Bis-Epipodophyllotoxin Etoposide 
Analogs. Bioorg. Med. Chem. 2015, 23 (13), 3542–3551. https://doi.org/10.1016/j.bmc.2015.04.022. 
(35)  Mansoori, B.; Mohammadi, A.; Davudian, S.; Shirjang, S.; Baradaran, B. The Different 
Mechanisms of Cancer Drug Resistance: A Brief Review. Adv. Pharm. Bull. 2017. 
https://doi.org/10.15171/apb.2017.041. 
(36)  Lee, K. H.; Xiao, Z. Podophyllotoxin and Its Analogues. In Anticancer Agents from Natural 
Products; Cragg, G. M., Kingston, D. G. I., Newman, D. J., Eds.; CRC Press: Boca Raton, 2005; 
71–85. 
(37)  Giorgi-Renault, S.; Desbène, S. Drugs That Inhibit Tubulin Polymerization: The Particular Case of 
Podophyllotoxin and Analogues. Curr. Med. Chem. Anticancer. Agents 2002, 2, 71–90. 
https://doi.org/10.2174/1568011023354353. 
(38)  Patric, G. L. An Introduction to Medicinal Chemistry, 4th ed.; Oxford University Press: Oxford, 
New York, 2009. 
(39)  Han, H.-W.; Qiu, H.-Y.; Hu, C.; Sun, W.-X.; Yang, R.-W.; Qi, J.-L.; Wang, X.-M.; Lu, G.-H.; Yang, 
Y.-H. Design, Synthesis and Anti-Cancer Activity Evaluation of Podophyllotoxin-Norcantharidin 
Hybrid Drugs. Bioorg. Med. Chem. Lett. 2016, 26 (14), 3237–3242. 
https://doi.org/10.1016/j.bmcl.2016.05.063. 
(40)  Kozlov, N. G.; Bondarev, S. L.; Kadutskii, A. P.; Basalaeva, L. I.; Pashkovskii, F. S. Tetronic Acid 
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 118 
in Reaction with Aromatic Aldehydes and 2-Naphthylamine. Investigation of Fluorescent and 
Nonlinear-Optical Characteristics of Compounds Obtained. Russ. J. Org. Chem. 2008, 44 (7), 1031–
1037. https://doi.org/10.1134/S1070428008070142. 
(41)  Liu, Y.; Tian, J.; Qian, K.; Zhao, X.; Morris-natschke, S. L.; Yang, L.; Nan, X.; Tian, X.; Lee, K. 
Recent Progress on C-4-Modified Podophyllotoxin Analogs as Potent Antitumor Agents. 2014, 
35(1), 1–62. https://doi.org/10.1002/med. 
(42)  Li, J.; Zhang, X.; Renata, H. Asymmetric Chemoenzymatic Synthesis of (−)-Podophyllotoxin and 
Related Aryltetralin Lignans. Angew. Chemie Int. Ed. 2019, 58 (34), 11657–11660. 
https://doi.org/10.1002/anie.201904102. 
(43)  Jeedimalla, N.; Johns, J.; Roche, S. P. Mechanistic Investigation and Implications of a Sacrificial 
Aniline for the Tandem Cascade Synthesis of 4-Aza-Podophyllotoxin Analogues. Tetrahedron Lett. 
2013, 54 (44), 5845–5848. https://doi.org/10.1016/j.tetlet.2013.08.071. 
(44)  Shearer, C.; Desaunay, O.; Zorc, S.; Samanta, S.; Jeedimalla, N.; Roche, S. Intercepted Knoevenagel 
Condensation for the Synthesis of Unsymmetrical Fused-Tricyclic 4H -Pyrans. Tetrahedron 2019, 
75 (4). https://doi.org/10.1016/j.tet.2019.130606 
(45)  Roy, A.; Ernsting, M. J.; Undzys, E.; Li, S. D. A Highly Tumor-Targeted Nanoparticle of 
Podophyllotoxin Penetrated Tumor Core and Regressed Multidrug Resistant Tumors. Biomaterials 
2015, 52 (1), 335–346. https://doi.org/10.1016/j.biomaterials.2015.02.041. 
(46)  Kim, S.; Kang, S.; Kim, G.; Lee, Y. Copper-Catalyzed Aza-Michael Addition of Aromatic Amines 
or Aromatic Aza-Heterocycles to α,β-Unsaturated Olefins. J. Org. Chem. 2016, 81 (10), 4048–4057. 
https://doi.org/10.1021/acs.joc.6b00341. 
(47)  Ranu, B. C. Solvent-Free, Catalyst-Free Michael-Type Addition of Amines to Electron-Deficient 
Alkenes. Arkivoc. 2002, 2002 (7), 76–81. https://doi.org/10.3998/ark.5550190.0003.709. 
(48)  Escalante, J.; Carrillo-Morales, M.; Linzaga, I. Michael Additions of Amines to Methyl Acrylates 
Promoted by Microwave Irradiation. Molecules 2008, 13 (2), 340–347. 
https://doi.org/10.3390/molecules13020340. 
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 119 
(49)  Wu, X. A.; Ying, P.; Liu, J. Y.; Shen, H. S.; Chen, Y.; He, L. Lithium Chloride-Assisted Selective 
Hydrolysis of Methyl Esters under Microwave Irradiation. Synth. Commun. 2009, 39 (19), 3459–
3470. https://doi.org/10.1080/00397910902778001. 
(50)  Barad, H. A.; Sutariya, T. R.; Brahmbhatt, G. C.; Parmar, N. J.; Lagunes, I.; Padrón, J. M.; 
Murumkar, P.; Sharma, M. K.; Yadav, M. R. A Catalyst- and Solvent-Free Multicomponent 
Synthesis and Docking Study of Some New Antiproliferative N 5-Allyl-Quinolylpyrido[2,3-
b][1,4]Benzodiazepinone Precursors. New J. Chem. 2016, 40 (6), 4931–4939. 
https://doi.org/10.1039/C5NJ03280F. 
(51)  Kobayakawa, T.; Ohashi, N.; Hirota, Y.; Takahashi, K.; Yamada, Y.; Narumi, T.; Yoshimura, K.; 
Matsushita, S.; Harada, S.; Tamamura, H. Flexibility of Small Molecular CD4 Mimics as HIV Entry 
Inhibitors. 2018, https://doi.org/10.1016/j.bmc.2018.10.011. 
(52)  Abdel-Magid, A. F.; Maryanoff, C. A. Reductive Amination of Aldehydes and Ketones with Weakly 
Basic Anilines Using Sodium Triacetoxyborohydride. Synlett. 1990, 1990 (9), 537–539. 
https://doi.org/10.1055/s-1990-21991. 
(53)  Byung, T. C.; Sang, K. K. Direct and Indirect Reductive Amination of Aldehydes and Ketones with 
Solid Acid-Activated Sodium Borohydride under Solvent-Free Conditions. Tetrahedron 2005, 61 
(24), 5725–5734. https://doi.org/10.1016/j.tet.2005.04.039. 
(54)  Cherepakhin, V. S.; Zaitsev, K. V; Churakov, A. V; Oprunenko, Y. F.; Zaitseva, G. S.; Karlov, S. 
S. N,O-Ditosylethanolamine as Effective Reagent for the Synthesis of Heterocyclic Tertiary 
Amine Salts. Phosphorus, Sulfur Silicon Relat. Elem. 2016, 191 (5), 693–698. 
https://doi.org/10.1080/10426507.2015.1067207. 
(55)  Helissey, P.; Giorgi-renault, S. Design and Effective Synthesis of the First 4-Aza- 2 , 3-
Didehydropodophyllotoxin Rigid Aminologue : A N-Methyl-4-[(3,4,5-Trimethoxyphenyl)Amino )]. 
J. Org. Chem. 2008, 73, 3642–3645. https://doi.org/10.1021/jo800166b 
(56)  Denmark, S. E.; Venkatraman, S. On the Mechanism of the Skraup - Doebner - Von Miller 
Quinoline Synthesis. 2006, No. 5, 1668–1676. https://doi.org/10.1021/jo052410h. 
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 120 
(57)  Carey, F. A.; Sundberg, R. J. Advanced Organic Chemistry Part A: Structure and Mechanisms, 5th 
ed.; Springer Science: New York, 2007, https://doi.org/10.1021/ed065pA139.2. 
(58)  Dayal, B.; Salen, G.; Toome, B.; Tint, G. S.; Shefer, S.; Padia, J. Lithium Hydroxide / Aqueous 
Methanol : Mild Reagent for the Hydrolysis of Bile Acid Methyl Esters. Steroids 1990, 55, 233–
237. 
(59)  Wu, C.; Fang, Y.; Larock, R. C.; Shi, F. Synthesis of 2 H -Indazoles by the [3 + 2] Cycloaddition of 
Arynes and Sydnones. Org. Lett. 2010, 12 (10), 2234–2237. https://doi.org/10.1021/ol100586r. 
(60)  Pradeep, D. J.; Dave, K. A Novel, Inexpensive and Less Hazardous Acid-Base Indicator. J. Lab. 
Chem. Educ. 2013, 1 (2), 34–38. https://doi.org/10.5923/j.jlce.20130102.04. 
(61)  Hyder, I.; Yedlapudi, D.; Kalivendi, S. V; Khazir, J.; Ismail, T.; Nalla, N.; Miryala, S.; Sampath 
Kumar, H. M. Synthesis and Biological Evaluation of Novel 4β-[(5-Substituted)-1,2,3,4-Tetrazolyl] 
Podophyllotoxins as Anticancer Compounds. Bioorg. Med. Chem. Lett. 2015, 25 (14), 2860–2863. 
https://doi.org/10.1016/j.bmcl.2015.04.053. 
(62)  Singh, M. S.; Chowdhury, S.; Koley, S. Advances of Azide-Alkyne Cycloaddition-Click Chemistry 
over the Recent Decade. Tetrahedron. 2016, 72, 5257–5283. 
https://doi.org/10.1016/j.tet.2016.07.044. 
(63)  Baughman, T. W.; Sworen, J. C.; Wagener, K. B. The Facile Preparation of Alkenyl Metathesis 
Synthons. Tetrahedron 2004, 60 (48), 10943–10948. https://doi.org/10.1016/j.tet.2004.09.021. 
(64)  Inverarity, I. A.; Hulme, A. N. Marked Small Molecule Libraries: A Truncated Approach to 
Molecular Probe Design. Org. Biomol. Chem. 2007, 5(4). https://doi.org/10.1039/b616494c. 
(65)  Karmakar, A.; Basha, M.; Venkatesh Babu, G. T.; Botlagunta, M.; Malik, N. A.; Rampulla, R.; 
Mathur, A.; Gupta, A. K. Tertiary-Butoxycarbonyl (Boc) – A Strategic Group for N-
Protection/Deprotection in the Synthesis of Various Natural/Unnatural N-Unprotected Aminoacid 
Cyanomethyl Esters. Tetrahedron Lett. 2018, 59 (48), 4267–4271. 
https://doi.org/10.1016/j.tetlet.2018.10.041. 
(66)  Ankati, H.; Biehl, E. Microwave-Assisted Benzyne-Click Chemistry: Preparation of 1H-
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 121 
Benzo[d][1,2,3]Triazoles. Tetrahedron Lett. 2009, 50 (32), 4677–4682. 
https://doi.org/10.1016/j.tetlet.2009.06.004. 
(67)  Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Click Chemistry: Diverse Chemical Function from a Few 
Good Reactions. Angew. Chem., Int. Ed. 2001, 40 (11), 2004–2021. https://doi.org/10.1433-
7851/01/4011-200 
(68)  Pasini, D. The Click Reaction as an Efficient Tool for the Construction of Macrocyclic Structures. 
Molecules 2013, 18 (8), 9512–9530. https://doi.org/10.3390/molecules18089512. 
(69)  Presolski, S. I.; Hong, V. P.; Finn, M. G. Copper-Catalyzed Azide-Alkyne Click Chemistry for 
Bioconjugation. In Current Protocols in Chemical Biology; John Wiley & Sons, Inc., 2011. 
https://doi.org/10.1002/9780470559277.ch110148. 
(70)  Labruère, R.; Gautier, B.; Testud, M.; Seguin, J.; Lenoir, C.; Desbène-Finck, S.; Helissey, P.; 
Garbay, C.; Chabot, G. G.; Vidal, M.; Giorgi-Renault, S. Design, Synthesis, and Biological 
Evaluation of the First Podophyllotoxin Analogues as Potential Vascular-Disrupting Agents. Chem. 
Med. Chem. 2010, 5 (12), 2016–2025. https://doi.org/10.1002/cmdc.201000305. 
(71)  Gemma, A.; Mayans, E.; Ballano, G.; Torras, J.; Díaz, A.; Jiménez, A. I.; Puiggalí, J.; Cativiela, C.; 
Alemán, C. Self-Assembly of Diphenylalanine with Preclick Components as Capping Groups. Phys. 











4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 122 
 
Supplementary information- Part I 
 Table of Contents 
7.1        Library 1 ............................................................................................................... 123 
7.1.1 Anilines .................................................................................................................. 123 
7.1.2 4-aza-podophyllotoxin analogues .......................................................................... 137 




4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 123 
7.1 Library 1 
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7.1.1.3.1 1H NMR spectrum of bis-functionalized product 
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7.1.1.4.1 1H NMR of bis functionalized product 
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 Synthesis of N-(3-(benzo[d][1,3]dioxol-5-ylamino)propyl)-4-methylbenzenesulfonamide (32) 
7.1.1.6.1 Mass spectrum of synthesized starting material 
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 4-aza-podophyllotoxin analogues 
 Analysis of ethyl 2-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-6,9-dihydro-[1,3]dioxolo[4,5-g] 
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 Analysis of ethyl 3-(9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-[1,3]dioxolo[4,5-g]furo[3,4-
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 Hydrolysis of 33a and 33b 
 Compound 2-(9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-
5(6H,8H,9H)-yl)acetic acid (39a) 
 
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 163 
 
Stellenbosch University https://scholar.sun.ac.za







































0.75 1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00 4.25 4.50 4.75 5.00 5.25 5.50 5.75 6.00 6.25 6.50 6.75 7.00
%
0











































4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 166 
 Compound 2-(8-oxo-9-(3,4,5-trimethoxyphenyl)-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-
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8.1 Click reactions used in the synthesis of Library 2 
 
Figure 1: Azides synthesized for use in azide alkyl cycloaddition.  
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 Synthesis of azides 40-45 
 Synthesis of N-(2-azidoethyl) naphthalene-1-sulfonamide (40) 
8.1.1.1.1 NMR analysis of Compound 47, intermediate in the synthesis of 40 
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8.1.1.1.2 Analysis of azide compound 40 
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 Synthesis of N-(3-azidopropyl)-5-(dimethylamino)naphthalene-1-sulfonamide (41) 






















































































































































































































 1000   2000   3000   4000  
Wavenumbers (cm-1)
Stellenbosch University https://scholar.sun.ac.za
4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 176 
8.1.1.2.2 Mass spectrum of intermediate Compound 50 
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 Compound 43 and Compound 44  
These compounds were synthesized by a member of the Stellenbosch University Group of Organic 
and Medicinal Chemistry group MG Botes and analysis aligns with expected literature values.  
 Synthesis of 1-(azidomethyl)-4-nitrobenzene (45)  
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 Synthesis of products 51a-56b 
 Synthesis of 52 4N-aza-posophyllotoxin with fluorescent marker 40 
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8.1.2.1.2 Compound 52b 
 
Compound 52b was not observed with NMR spectroscopy and the starting material was recovered. 
KG88
m/z























































4-AZA-PODOPHYLLOTOXIN ANALOGUES AS ANTI-CANCER AGENTS 183 
 Synthesis of 54 4N-aza-podophyllotoxin with meta-benzylic acid  
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8.1.2.2.2 Compound 54b 
The compound was not synthesized in sufficient quantities for further analysis. 
 Synthesis of 55 4N-aza-podophyllotoxin with para-benzylic acid  
8.1.2.3.1 Compound 55a 
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8.1.2.3.2 Compound 55b 
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 Synthesis of 56 4N-aza-podophyllotoxin with 4-nitrobenzene  
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